POS-002 | THE EFFECT OF ANG-3777 ON THE GROWTH OF C-MET-EXPRESSING HUMAN TUMOR CELLS IN IMMUNOCOMPROMISED MICE | Eric Krauter | Received |
POS-003 | TOTAL RNA FROM BONE MARROW CELLS INDUCES LIVER REGENERATION BY CO-ACTIVATING EARLY APOPTOSIS AND PROLIFERATION PROCESSES | Murat Shagidulin | Received |
POS-004 | TOWARD A BIO-ENGINEERED PERIOSTEUM | Julie Manon | Received |
POS-006 | THE COVID19 PANDEMIC IMPACT ON TISSUE DONATION, LESSONS LEARNED | Lucas Lozano | Received |
POS-007 | EX VIVO MACHINE PERFUSION TO ASSESS ISCHEMIA REPERFUSION INJURY OF AMPUTATED PORCINE LIMBS | Ahmed Fahiem Abdelsalam Emara | Received |
POS-008 | EVALUATION OF EPIDEMIOLOGICAL FEATURES OF PERMANENT HYPOPARATHYROIDISM PATIENTS WHILE AS A CANDIDATE OF PARATHYROID TRANSPLANTATION | Harika Salepcioglu Kaya | Received |
POS-010 | IMPROVING THE TECHNIQUE OF A HETEROTOPIC VASCULARIZED COMPOSITE HINDLIMB ALLOTRANSPLANTATION IN THE PIG | Stefanie Hirsiger | Received |
POS-011 | AUTOTRANSPLANTATION OF UTERUS ON ANIMAL MODEL PRELIMINARY TO CLINICAL APPLICATION | Emanuele Federico Kauffmann | Received |
POS-012 | NEW SURGICAL APPROACH TO USE HUMAN ALLOGRAFT AS BIOLOGICAL DRESSING IN PATIENTS WITH EPIDERMOLYSIS BULLOSA (EB) | Magdalena Nita | Received |
POS-013 | EFFICIENT RECELLULARIZATION OF HUMAN VASCULAR GRAFTS WITH PATIENT DERIVED ENDOTHELIAL CELLS | Hector Tejeda Mora | Received |
POS-015 | A SYSTEMATIC REVIEW OF ETHICAL ISSUES IN ORGANOIDS RESEARCH FOR USE IN TRANSPLANTATION | Dide de Jongh | Received |
POS-016 | THE INFLUENCE OF SOCIOECONOMIC FACTORS ON ORGAN DONATION IN IRAN: FINDINGS FROM A SINGLE CENTER STUDY | Sanaz Dehghani | Received |
POS-017 | QUALITY OF LIFE (QOL) OF RENAL DONORS COMPARED TO FIRST-DEGREE RELATIVES OF HAEMODIALYSIS PATIENTS (THE HIDDEN PATIENT). | Sarah Zaman | Received |
POS-019 | WHAT ARE THE PSYCHOSOCIAL FACTORS INFLUENCING ACCESS TO KIDNEY TRANSPLANTATION AND TRANSPLANT OUTCOMES FOR CHILDREN? A SYSTEMATIC LITERATURE REVIEW | Ji Soo Kim | Received |
POS-020 | FROM THE WAITING LIST TO TRANSPLANTATION: HOW IS PATIENTS PERCEPTION OF PROFESSIONALS EVOLVING ALONG THE WAY? | Lia Bellis | Received |
POS-021 | MEDICATION ADHERENCE IN KIDNEY TRANSPLANT PATIENTS: SINGLE CENTRE COMPARISON BETWEEN PATIENTS 12-18 MONTHS AND AT LEAST 7 YEARS POST-TRANSPLANT | Rosie Heape | Received |
POS-022 | THE FIRST ITALIAN UTERUS TRANSPLANTATION DURING COVID-19: A PSYCHOLOGICAL AND PSYCHIATRIC EVALUATION IN FIVE CANDIDATES | Maria Luisa Pistorio | Received |
POS-023 | EPIDEMIOLOGICAL STUDY OF TRICUSPID REGURGITATION AFTER CARDIAC TRANSPLANTATION. DOES IT INFLUENCE SURVIVAL? | Raquel López-Vilella | Received |
POS-025 | INVASIVE PULMONARY ASPERGILLOSIS AFTER HEART TRANSPLANTATION | Maria Simonenko | Received |
POS-026 | ARE HEART TRANSPLANT PATIENTS AT HIGHER RISK FOR MORTALITY FOLLOWING SARS-COV-2 INFECTION? SINGLE CENTRE EXPERIENCE | Sandro Sponga | Received |
POS-027 | COVID-19 AND CARDIAC TRANSPLANTATION. EXPERIENCE IN A TERTIARY HOSPITAL | Víctor Donoso Trenado | Received |
POS-029 | EARLY EXPERIENCE WITH A NEW STORAGE DEVICE FOR COLD PRESERVATION | Johannes Goekler | Received |
POS-030 | DISCARDED GRAFTS AFTER CARDIAC EX-VIVO PRESERVATION | Sandro Sponga | Received |
POS-032 | TEMPORAL RATES OF CELLULAR REJECTION IN THE FIRST TWO YEARS FOLLOWING HEART TRANSPLANTION IN A CONTEMPORARY COHORT. | Paul Callan | Received |
POS-033 | SAIREITO INDUCED THE SUPPRESSION OF DONOR-SPECIFIC ANTIBODY IN A MURINE CARDIAC ALLOGRAFT TRANSPLANT MODEL | Yasuto Yamamoto | Received |
POS-035 | FATE OF IMPLANTED AORTIC SCAFFOLDS- ROLE OF EXTRACELLULAR AND IMMUNE PROTEINS | Debashish Banerjee | Received |
POS-036 | INTESTINAL DONOR CRITERIA: IS THERE ROOM FOR IMPROVEMENT? | Mathias Clarysse | Received |
POS-037 | INFECTIONS IN SMALL BOWEL AND MULTIVISCERAL TRANSPLANT RECIPIENTS IN A UK CENTRE | Samantha Koh | Received |
POS-038 | EXTERNAL VALIDATION OF A CLINICO-HISTOPATHOLOGICAL COMPOSITE SCORING SYSTEM TO PREDICT GRAFT FUNCTION IN MARGINAL DONORS. | Mercedes Ruiz Hernández | Received |
POS-039 | IMPROVING KIDNEY UTILIZATION IN DEVELOPING COUNTRIES | Joel de Andrade | Received |
POS-040 | IMPACT OF COMBINED CLINICAL AND HISTOLOGICAL ALLOCATION CRITERIA FOR KIDNEY TRANSPLANTS FROM MARGINAL DONORS. | Alessia Terulla | Received |
POS-041 | URGENCY PRIORITY PATIENTS FOR KIDNEY TRANSPLANTATION, SINGLE CENTER EXPERIENCE | Sahin Eyupoglu | Received |
POS-042 | MACHINE LEARNING IMPROVES THE ACCURACY OF KIDNEY TRANSPLANT OUTCOME PREDICTIVE MODELS | Laszlo Szabo | Received |
POS-043 | ESTIMATION OF HEALTH-RELATED QUALITY OF LIFE IN A GREEK COHORT OF KIDNEY TRANSPLANT RECIPIENTS USING THE KIDNEY TRANSPLANT QUESTIONNAIRE 25 (KTQ-25) | Vasileios Koutlas | Received |
POS-044 | KIDNEY ALLOCATION RULES SIMULATOR | Bruno Lima | Received |
POS-045 | IMPLEMENTATION OF THE KIDNEY TEAM AT HOME INTERVENTION: EVALUATING GENERALIZABILITY, IMPLEMENTATION PROCESS, AND EFFECTS | Steef Redeker | Received |
POS-046 | COMPARING SCORES FOR PREDICTING KIDNEY TRANSPLANTATION OUTCOMES | Bruno Lima | Received |
POS-047 | KIDNEY TRANSPLANTATION FROM ELDERLY DONORS THE EXPERIENCE OF A REFERENCE CENTER IN CROATIA | Stela Zivcic-Cosic | Received |
POS-048 | MACHINE LEARNING-BASED PREDICTIVE MODEL FOR OUTCOME OF COVID-19 IN KIDNEY TRANSPLANT RECIPIENTS | Ignacio Revuelta | Received |
POS-049 | 18FFDG PET/CT IMAGING DISPROVES RENAL ALLOGRAFT ACUTE REJECTION IN KIDNEY TRANSPLANT RECIPIENTS WITH ACUTE KIDNEY INJURY: A VALIDATION COHORT | Francois JOURET | Received |
POS-050 | PREOPERATIVE NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) PREDICTS DELAYED GRAFT FUNCTION (DGF) IN RENAL ALLOTRANSPLANTATION. | Vasileios Tatsis | Received |
POS-052 | URINARY CXCL10 AT 6 MONTHS AFTER KIDNEY TRANSPLANTATION PREDICTS THE HISTOLOGIC FINDINGS OF 1-YEAR SURVEILLANCE BIOPSY | EMILIO RODRIGO CALABIA | Received |
POS-053 | DICKKOPF 3-PRECISELY REFLECTS SUBSEQUENT KIDNEY ALLOGRAFT DETERIORATION | Antonia Schuster | Received |
POS-054 | UREMIC TOXIN LEVELS ARE ASSOCIATED WITH GUT MICROBIOME CHANGES IN KIDNEY TRANSPLANT RECIPIENTS | Susana Sampaio Norton | Received |
POS-055 | IMPACT OF KLOTHO AS A BIOMARKER FOR CANCER SURVEILLANCE IN KIDNEY TRANSPLANT RECIPIENTS | Woo Yeong Park | Received |
POS-056 | SYSTEMATIC REVIEW OF NON-INVASIVE IMAGING TECHNIQUES USED TO DIRECTLY EVALUATE THE MICROCIRCULATION IN KIDNEY OR LIVER TRANSPLANTATION | Dilan Dabare | Received |
POS-057 | LOW INVASIVE SPME TISSUE SAMPLING AS A NEW TOOL FOR GRAFT QUALITY ASSESSMENT | Natalia Warmuzinska | Received |
POS-058 | FUNCTIONAL CATEGORIES DETERMINED BY RNA-SEQ IN URINE OF KIDNEY TRANSPLANT PATIENTS WITH ACUTE REJECTION COMPARED WITH LONG-TERM ALLOGRAFT SURVIVAL | Cristian Alvarez | Received |
POS-059 | HOW DONOR CYP3A5 EXPRESSION AFFECT TRANSPLANTATION OUTCOMES IN CAUCASIAN POPULATION OF RENAL TRANSPLANT RECIPIENTS | Karola Warzyszynska | Received |
POS-060 | Glomerular proteome characterization during active antibody-mediated rejection in kidney transplantation highlights interferon-related endothelial stress markers | Bertrand Chauveau | Received |
POS-061 | EARLY PREDICTION OF RENAL GRAFT FUNCTION: ANALYSIS OF A MULTI-CENTRE, MULTI-LEVEL DATA SET | Arturo Blázquez Navarro | Received |
POS-063 | DEGRADATION OF KEY CYTOSKELETAL AND GLOMERULAR BASEMENT MEMBRANE PROTEINS ASSOCIATE TO SUBOPTIMAL OUTCOMES IN KIDNEY TRANSPLANTATION | Rebecca Vaughan | Received |
POS-064 | PARATHYROID HORMONE (PTH) SERUM LEVEL AS PREDICTOR OF OUTCOME IN RENAL TRANSPLANT: A RETROSPECTIVE STUDY | Giuseppe Ietto | Received |
POS-065 | CALCIFICATION CT ASSESSED CALCIUM SCORING: EFFECTS OF RENAL TRANSPLANT RECIPIENT OUTCOMES | Laura Clementoni | Received |
POS-066 | LONG TERM OUTCOMES OF KIDNEY TRANSPLANT RECIPIENTS WITH CT ASSESSED SARCOPAENIA | Christopher Seet | Received |
POS-067 | IS ACCOMMODATION AN UNHARMFUL PROCESS IN ABO INCOMPATIBLE KIDNEY TRANSPLANT? | Carlos Couceiro | Received |
POS-068 | ANTITHROMBOTIC MANAGEMENT IN KIDNEY TRANSPLANTATION AN EUROPEAN SURVEY STUDY | Tamar van den Berg | Received |
POS-069 | OPTIMIZATION OF ERYTHROPOIETIN STIMULATING AGENTS FOR POST-TRANSPLANT ANEMIA IN KIDNEY RECIPIENTS: PROSPECTIVE RANDOMIZED CONTROLLED TRIAL | Ayman Maher | Received |
POS-072 | IS SAFE OOCYTE DONATION PREGNANCY AFTER KIDNEY TRANSPLANT? | Alessandro Tomassetti | Received |
POS-074 | THE CURRENT PRACTICE OF LIVE DONOR NEPHRECTOMY IN TURKEY: RESULTS OF A NATIONWIDE SURVEY | Bakytbek Mankiev | Received |
POS-075 | DOWN-REGULATION OF INFLAMMATORY SIGNALING PATHWAYS DESPITE UP-REGULATIONOF TOLL-LIKE RECEPTORS; THE EFFECTS OF CORTICOSTEROID THERAPY IN BRAIN-DEAD | Sanaz Dehghani | Received |
POS-076 | DECISION MAKING ON ORGAN DONATION: THE REASON OF REFUSING FOR DONATION IN NON-DONOR FAMILIES | Sanaz Dehghani | Received |
POS-077 | KIDNEY RE-TRANSPLANT: SINGLE CENTER EXPERIENCE FROM THE MIDDLE EAST | Osama Gheith | Received |
POS-078 | EFFICACY AND SAFETY OF MARGINAL GRAFTS FROM EXPANDED CRITERIA DONOR (ECD) AND DONATION AFTER CIRCULATORY DEATH (DCD) IN ERDERLY RECIPIENTS | Ana Dominguez | Received |
POS-079 | KIDNEY TRANSPLANTATION FROM ELDERLY DONORS: SINGLE-CENTER EXPERIENCE | hakan sozen | Received |
POS-080 | DECEASED-DONOR INITIATED CHAINS: THREE-YEARS EXPERIENCE OF THE ITALIAN DECK PROGRAM | Lucrezia Furian | Received |
POS-082 | CHANGES ON MINERAL METABOLISME AFTER LIVING KIDNEY DONATION. ARE THEY IMPORTANT? | NURIA SERRA | Received |
POS-083 | THE IMPACT OF PRETRANSPLANT RENAL BIOPSY ON THE EVALUATION OF PROSPECTIVE LIVING KIDNEY DONORS | Christina Melexopoulou | Received |
POS-084 | LONG-TERM OUTCOMES IN OLDER KIDNEY TRANSPLANT RECIPIENTS FROM OLDER DONORS. A PROPENSITY SCORE ANALYSIS | Elena Cuadrado | Received |
POS-085 | CLINICAL UTILITY AND EVOLUTION OF DONOR SERUM LACTATE DURING NORMOTHERMIC REGIONAL PERFUSION IN UNCONTROLLED DONATION AFTER CIRCULATORY DEATH (UDCD) | David Paredes-Zapata | Received |
POS-086 | INDIVIDUAL RISK POST-LIVING KIDNEY DONATION: A META-ANALYSIS OF THE EFFECTS OF DONOR DEMOGRAPHIC CHARACTERISTICS | Maria Irene Bellini | Received |
POS-087 | THE IMPACT ON RECIPIENT DEMOGRAPHICS ON OUTCOMES FROM LIVING DONOR KIDNEYS | Mikhail Nozdrin | Received |
POS-088 | AGING IN LIVING DONATION. PERIOPERATIVE ANALYSIS | Lucía Peña | Received |
POS-090 | MIDTERM OUTCOMES OF LIVE KIDNEY TRANSPLANTATION FROM ELDERLY DONORS | Emin Baris Akin | Received |
POS-091 | ORGAN DONATION IN A DEVELOPING CARIBBEAN COUNTRY: A SINGLE CENTRE EXPERIENCE IN TRINIDAD AND TOBAGO | Hassina Mohammed | Received |
POS-092 | LONG-TERM OUTCOMES WITH EXPANDED CRITERIA DONORS IN KIDNEY TRANSPLANTATION: 10 YEAR EXPERIENCIA | Andrea Elena García | Received |
POS-093 | LONG TERM RENAL OUTCOMES IN LIVING DONORS WITH ASYMPTOMATIC NEPHROLITHIASIS | Christopher Seet | Received |
POS-094 | MEETING PATIENT EXPECTATIONS MATTERS MORE THAN UK KDRI SCORE FOR QUALITY OF LIFE OUTCOMES AFTER KIDNEY TRANSPLANTATION | Hannah Maple | Received |
POS-095 | ESTRADIOL TREATMENT MODULATES ESTRADIOL RECEPTORS EXPRESSION AND REDUCES RENAL INJURY AFTER BRAIN DEATH IN FEMALE RATS | Cristiano Correia | Received |
POS-096 | DBD AND DCD SPECIFIC KIDNEY PROTEIN PROFILES ASSOCIATED WITH 12-MONTH POST-TRANSPLANT KIDNEY FUNCTION | Priyanka Joshi | Received |
POS-097 | EXPERIENCE WITH EXPANDED CRITERIA DONORS IN KIDNEY TRANSPLANTATION IN THE COLOMBIAN CARIBBEAN REGION | Andrea Elena García | Received |
POS-098 | ANTI-HLA-DP ANTIBODIES POSITIVE - A RETROSPECTIVE REVIEW OF OUTCOMES IN RENAL TRANSPLANTATION- SINGLE CENTRE EXPERIENCE | Oana Piscoran | Received |
POS-099 | ATHENA IMPACT OF PRIMARY IMMUNOSUPPRESSION ON DEVELOPMENT OF DE NOVO DONOR SPECIFIC ANTIBODIES WITHIN 12 MONTHS POST-KIDNEY TRANSPLANTATION. | Anja Elssser | Received |
POS-100 | CLUSTERS OF ANTI HLA CLASS II LUMINEX RESPONSES REVEALED BY SIMPLE MACHINE LEARNING ALGORITHMS. IMPLICATIONS FOR DSA STUDIES. | Asimina FYLAKTOU | Received |
POS-101 | DETECTION AND QUANTIFICATION OF IMMUNOLOGICALLY RELEVANT ALLOANTIBODY-HLA INTERACTIONS USING MICROFLUIDIC ANTIBODY AFFINITY PROFILING | Ashley Priddey | Received |
POS-102 | HIGH CHOLESTEROL AND AGING NEGATIVELY INFLUENCE RENAL CAPILLARY DENSITY AND TUBULE VILLIN EXPRESSION BY DECREASING CAPILLARY VEGF AND NITRIC OXIDE | B. Handan Ozdemir | Received |
POS-103 | CLINICAL IMPLICATION OF C1Q DEPOSITION IN KIDNEY TRANSPLANTATION | Eun-Ah Jo | Received |
POS-104 | SINGLE KIDNEY TRANSPLANT USING ORGANS WITH KARPINSKI/REMUZZI SCORE 6 OR HIGHER: A TABOO TO DISPEL? | Fabio Vistoli | Received |
POS-105 | RESEARCH BIOPSIES IN KIDNEYS FOR TRANSPLANT: AUDIT TO COMPARE CLINICAL SAFETY WITH TISSUE QUALITY | James Hunter | Received |
POS-110 | DESENSITIZATION TREATMENT AS AN OPTION FOR HIGH IMMUNOLOGICAL RISK RENAL TRANSPLANT CANDIDATES: SINGLE CENTER EXPERIENCE | Cinthia Baldallo | Received |
POS-111 | FREQUENCY OF HLA-SPECIFIC IGE ANTIBODIES IN SOLID ORGAN TRANSPLANTATION ANALYSED BY SINGLE-ANTIGEN BEADS-BASED IMMUNOASSAY | Jasmin Mucha | Received |
POS-112 | PRETRANSPLANT NATURAL KILLER CELLS LEVEL IS INVOLVED IN REJECTION AND OPPORTUNISTIC INFECTION ONSET WITHIN THE FIRST YEAR AFTER KIDNEY TRANSPLANTATION | Florence RUNYO | Received |
POS-114 | DECLINE IN CD4 T CELLS EXPRESSING T CELL IMMUNORECEPTOR WITH IG AND ITIM DOMAINS UNDERLIES DONOR-SPECIFIC HYPORESPONSIVENESS POST TRANSPLANTATION? | Amy van der List | Received |
POS-115 | THE HLA-DR4-DQ8 PHENOTYPE OF THE RECIPIENT IS ASSOCIATED WITH INCREASED MORTALITY AFTER KIDNEY TRANSPLANTATION | Kit Lund | Received |
POS-116 | CLINICAL OUTCOMES OF KIDNEY TRANSPLANT RECIPIENTS WITH C1Q-BINDING DE NOVO DONOR-SPECIFIC ANTIBODIES: A SINGLE-CENTER EXPERIENCE | Stathis Tsiakas | Received |
POS-119 | DIMINISHED TREG CELLS IN PERIPHERAL BLOOD IS ASSOCIATED WITH LATE ANTIBODY MEDIATED REJECTION AFTER FIRST YEAR POST KIDNEY TRANSPLANT. | Mariana Seija | Received |
POS-120 | VALIDATION OF C3, IC3B, C3D, C4D, PROPERDIN C5 AND C5B-9 ASSAYS TO MONITOR COMPLEMENT ACTIVATION IN KIDNEY TRANSPLANT PATIENTS | Rosa Lammerts | Received |
POS-121 | HUMAN PODOCYTE INJURY OF KIDNEY ALLOGRAFTS IN ANTIBODY-MEDIATED REJECTION | Jie Chen | Received |
POS-122 | MICROVASCULAR INFLAMMATION IN NO-DSA MEDIATED CHRONIC REJECTION AFTER KIDNEY TRANSPLANTATION | Rostand Emmanuel Nguefouet momo | Received |
POS-123 | ANGIOTENSIN II TYPE-1 RECEPTOR (AT1R) ANTIBODIES ARE ASSOCIATED WITH INFERIOR RENAL ALLOGRAFT SURVIVAL | Paul Martin | Received |
POS-124 | THE ROLE OF T LYMPHOCYTES SUBPOPULATIONS IN KIDNEY TRANSPLANTATION | Asimina FYLAKTOU | Received |
POS-125 | CHANGES OF REGULATORY T LYMPHOCYTES IN KIDNEY TRANSPLANTATION | Efstratios Kasimatis | Received |
POS-126 | PATTERNS OF IGG REBOUND AFTER IMLIFIDASE TREATMENT | Angela Maldonado | Received |
POS-127 | MUSEKAL - A MULTI-CENTRE NON-INTERVENTIONAL STUDY TO ASSESS THE TOLERABILITY AND EFFECTIVENESS OF ENVARSUS IN DE NOVO KIDNEY TRANSPLANT PATIENTS | Jarmila Dedochová | Received |
POS-128 | MUSEKAL - ASSESSING TOLERABILITY AND EFFECTIVENESS OF ENVARSUS IN KIDNEY TRANSPLANT PATIENTS CONVERTED FROM OTHER TACROLIMUS FORMULATIONS | Marcus Seemann | Received |
POS-129 | EFFECT OF TACROLIMUS EXPOSURE ON EVEROLIMUS-BASED IMMUNOSUPPRESSION IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: A 24-MONTH ANALYSIS FROM TRANSFORM STUDY | Franco Citterio | Received |
POS-131 | PAIRED STUDY OF KIDNEY DONORS COMPARING TWO FORMULATIONS OF PROLONGED-RELEASE TACROLIMUS (ADVAGRAF VS ENVARSUS). | Verónica López Jiménez | Received |
POS-132 | SENSITIVITY TO TACROLIMUS NEPHROTOXICITY AND LONG-TERM GRAFT OUTCOMES IN KIDNEY TRANSPLANT RECIPIENTS | Sabine Vollenbroek | Received |
POS-133 | COMPARISON OF BASILIXIMAB VS NO INDUCTION ON 24-MONTHS RENAL FUNCTION IN KIDNEY TRANSPLANT RECIPIENTS IN THE TACROLIMUS ERA | Zdenek Lys | Received |
POS-135 | COMPARISON OF BASILIXIMAB AND R-ATG ON ACUTE REJECTION RISK IN HIGH IMMUNOLOGICAL RISK RENAL TRANSPLANT RECIPIENTS | Hatem Ali | Received |
POS-136 | ASSOCIATION OF TACROLIMUS TROUGH LEVEL AND DAILY DOSE RATIO WITH OUTCOMES IN A PROSPECTIVE PREVALENT COHORT OF KIDNEY TRANSPLANT RECIPIENTS | Orsolya Cseprekal | Received |
POS-137 | AN EFFECT OF DONOR-RECIPIENT CYP3A5 GENOTYPE COMBINATION ON TACROLIMUS EXPOSURE IN RENAL TRANSPLANT RECIPIENTS | Karola Warzyszynska | Received |
POS-138 | IMPACT OF POLYCLONAL ANTI-T-LYMPHOCYTE GLOBULIN ON THE RECURRENCE OF IGA NEPHROPATHY AFTER KIDNEY TRANSPLANTATION: THE PIRAT STUDY | nicolas maillard | Received |
POS-139 | THE BURDEN OF GASTRO-INTESTINAL COMPLAINTS IN KIDNEY TRANSPLANT RECIPIENTS USING TACROLIMUS WITH AND WITHOUT MYCOPHENOLATE MOFETIL. | Zainab Al Fatly | Received |
POS-140 | IMMUNOREGULATION AFTER RITUXIMAB INDUCTION IN BLOOD GROUP INCOMPATIBLE LIVING-DONOR RENAL TRANSPLANTATION 2 YEAR DATA OF A PROSPECTIVE PILOT STUDY | Rolf Weimer | Received |
POS-141 | LONG- TERM OUTCOMES OF ABO INCOMPATIBLE LIVING KIDNEY TRANSPLANTATION IN GREECE | Christina Melexopoulou | Received |
POS-142 | COVID-19 AND THE KIDNEY: SINGLE-CENTER EXPERIENCE FROM TURKEY | Sanem Cimen | Received |
POS-143 | RECURRENT URINARY TRACT INFECTIONS AMONG RENAL TRANSPLANT RECIPIENTS: RISK FACTORS AND OUTCOME WITH DEVELOPING RESISTANCE | osama Gheith | Received |
POS-144 | CARBAPENEMS PROPHYLAXIS AND EXTENDED-SPECTRUM CEPHALOSPORINS-RESISTANT ENTEROBACTERALES URINARY TRACT INFECTION IN KIDNEY TRANSPLANT RECIPIENTS | Jackrapong Bruminhent | Received |
POS-145 | EFFECT OF MYCOPHENOLIC ACID AND TACROLIMUS ON THE INCIDENCE OF INFECTIONS AFTER KIDNEY TRANSPLANTATION IN CONTRAST WITH ACUTE KIDNEY REJECTION. | Matej Vnu&269;ák | Received |
POS-146 | TUBERCULOSIS IN KIDNEY TRANSPLANT RECIPIENTS IN A UNIVERSAL ISONIAZID PROPHYLAXIS SETTING | Jackrapong Bruminhent | Received |
POS-147 | COVID-19 POSITIVE KIDNEY TRANSPLANT RECIPIENTS BEHAVE DIFFERENTLY DURING THE UNREMITTING STAGE WITH OPTIMIZED ANTICOAGULATION AND IMMUNOSUPPRESSION | osama Gheith | Received |
POS-148 | ACUTE KIDNEY INJURY AMONG COVID-19 POSITIVE PATIENTS IS ASSOCIATED WITH HIGHER MORTALITY: SINGLE CENTER EXPERIENCE. | osama Gheith | Received |
POS-149 | CRITICALLY ILL COVID-19 POSITIVE KIDNEY TRANSPLANT RECIPIENTS BEHAVE DIFFERENTLY COMPARED TO NON-TRANSPLANT PATIENTS: SINGLE CENTER EXPERIENCE. | Ayman Maher | Received |
POS-151 | GENDER AND AGE DISPARITY IN INFECTIOUS COMPLICATIONS AFTER KIDNEY TRANSPLANTATION. | Matej Vnu&269;ák | Received |
POS-154 | MAY ROUTINE BIOMARKERS FOR THE SEVERITY OF COVID-19 PNEUMONIA DIFFERENCE SARS-COV-2 INFECTION TO OTHERS INFECTIONS IN KIDNEY TRANSPLANT RECIPIENTS? | María Molina | Received |
POS-155 | NOVEL AGENTS FOR ERADICATING HEPATITIS C VIRUS IN RENAL TRANSPLANT RECIPIENTS | Rosita Greco | Received |
POS-156 | RISK FACTORS FOR MORTALITY IN KIDNEY TRANSPLANT PATIENTS INFECTED BY SARS-COV-2 IN SOUTH OF SPAIN | Verónica López Jiménez | Received |
POS-157 | CLINICAL PREDICTORS OF COVID-19 DISEASE SEVERITY IN KIDNEY TRANSPLANT RECIPIENTS | Pedro Lisboa Gonalves | Received |
POS-158 | WILLINGNESS OF KIDNEY TRANSPLANT RECIPIENTS TO RECEIVE COVID-19 VACCINE | Ieva Ziedina | Received |
POS-160 | REMDESIVIR IS USEFUL AND SAFE IN KIDNEY TRANSPLANTAT PATIENTS WITH SARS-CoV PNEUMONIAE. | Judit Cacho | Received |
POS-161 | EXTERNAL URETERIC STENT VS. INTERNAL DOUBLE J STENT IN RENAL TRANSPLANTATION: OCCURRENCE OF URINARY TRACT INFECTIONS AND UROLOGIC COMPLICATIONS | Margriet Hazenberg | Received |
POS-163 | KIDNEY TRANSPLANTATION ACTIVITY DURING COVID PANDEMIC - A SINGLE CENTER EXPERIENCE | AHMAD MIRZA | Received |
POS-165 | RISK FACTORS FOR HOSPITAL ADMISSIONS AFTER MONOCLONAL ANTIBODIES FOR COVID-19 INFECTION IN SOLID ORGAN TRANSPLANT RECIPIENTS | Lana Hasan | Received |
POS-166 | TRANSPLANT RELATED RISK FACTORS ANALYSIS OF MORTALITY IN RENAL TRANSPLANT RECIPIENTS WITH COVID-19 - A SINGLE CENTER-BASED RETROSPECTIVE STUDY | Dr Ashish Sharma | Received |
POS-167 | THE SERUM LEVELS OF ANTI-SARS-COV-2 ANTIBODIES REMAIN DETECTABLE AT 9 MONTHS POST COVID-19 IN SYSTEMATICALLY SCREENED KIDNEY TRANSPLANT RECIPIENTS | Louis FIRKET | Received |
POS-169 | COVID-19 infection rates/outcomes in clinically extremely vulnerable renal replacement therapy patients admitted for procedures during the pandemic | Connie Rose Gabor | Received |
POS-172 | PREDICTIVE FACTORS AND OUTCOMES OF URINARY TRACT INFECTIONS AFTER KIDNEY TRANSPLANTATION: A RETROSPECTIVE COHORT STUDY | Tlili Syrine | Received |
POS-174 | URINARY TRACT INFECTIONS AND LONG TERM OUTCOMES AFTER PEDIATRIC RENAL TRANSPLANTATION | Aydincan Akdur | Received |
POS-175 | ROUTINE TRANSPLANT URETERIC STENT CULTURE - UTILITY IN IDENTIFYING PATIENTS AT HIGHER RISK OF URINARY TRACT INFECTION | Bynvant Sandhu | Received |
POS-177 | SARS-COV-2 IGG SEROPREVALENCE AND FACTORS AFFECTING ITS LEVELS IN KIDNEY TRANSPLANT RECIPIENTS DURING SECOND PEAK OF COVID-19 PANDEMIC | Maria Magicova | Received |
POS-178 | THE BITTER SWEET ENEMY OF RENAL TRANSPLANT RECIPIENTSA DEMI DECADE EXPERIENCE OF POST RENAL TRANSPLANT GRAFT OUTCOMES IN DIABETIC KIDNEY DISEASE | Kevin T John Keeppallil | Received |
POS-179 | NOVEL CORONAVIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS (A SINGLE-CENTER EXPERIENCE) | Elena Semenova | Received |
POS-180 | INFLUENCE OF VITAMIN D STATUS ON THE PROGNOSIS OF COVID 19 IN PATIENTS WITH KIDNEY TRANSPLANT | Jessica Marlia Ugalde Altamirano | Received |
POS-181 | EFFECTS OF OXYGEN DURING HYPOTHERMIC MACHINE PERFUSION IN AN EXPERIMENTAL PORCINE MODEL OF KIDNEY DONATION AFTER CARDIAC DEATH. ADDED CONTROVERSIES | Victoria Gomez | Received |
POS-182 | PREDICTORS OF DEVELOPMENT AND DURATION OF DELAYED GRAFT FUNCTION (DGF) IN MARGINAL KIDNEYS WITH HYPOTHERMIC PULSATILE MACHINE PERFUSION (HPMP) | Ana Dominguez | Received |
POS-183 | DELAYED GRAFT FUNCTION; DOES IT REALLY BURDEN FOR DECEASED DONOR KIDNEY TRANSPLANTS? | Hakan Sozen | Received |
POS-184 | HYPOTHERMIC MACHINE PERFUSION CAN BE SAFELY USED TO PROLONG COLD ISCHEMIA TIME IN DECEASED DONOR KIDNEY TRANSPLANTATION | Riccardo Pravisani | Received |
POS-185 | IMPACT ON KIDNEY TRANSPLANTATION OF THE PERCENTAGE OF T LYMPHOCYTES ISOLATED FROM HEPATIC PERFUSATE OF MULTI-ORGAN DECEASED BRAIN DONORS. | Duilio Pagano | Received |
POS-186 | DOES OXYGENATION AT PO2 21 DURING HYPOTHERMIC MACHINE PERFUSION (HMP) IMPROVE THE CLINICAL OUTCOME OF DECEASED DONOR KIDNEY TRANSPLANTATION? | Riccardo Pravisani | Received |
POS-187 | FROSTBITE LESIONS OF KIDNEYS RETRIEVED FROM DECEASED DONORS AND FAILED USE: A NATIONAL APPROACH BY THE ITALIAN NATIONAL TRANSPLANT CENTER | Raffaele Donadio | Received |
POS-188 | DUAL AND OPPOSITE COSTIMULATORY TARGETING WITH A NOVEL HUMAN RECOMBINANT PROTEIN PREVENTS RENAL WARM IRI AND ALLOGRAFT REJECTION IN MURINE MODELS | Jordi Guiteras | Received |
POS-189 | FUNCTIONAL MRI ASSESSMENT DURING EX VIVO NORMOTHERMIC PERFUSION: THE FIRST EXPERIENCE WITH DISCARDED HUMAN KIDNEYS | Tim Hamelink | Received |
POS-190 | COMPARISON BETWEEN KIDNEY TRANSPLANTATION AFTER CIRCULATORY DEATH AND AFTER BRAIN DEATH:A MONOCENTRIC RETROSPECTIVE STUDY AFTER TWO YEARS OF FOLLOW-UP | Laura Tonelli | Received |
POS-191 | Validation of the preclinical models for renal ischemia reperfusion injury: a systematic review | Lente Lerink | Received |
POS-192 | THE EFFECT OF A KETOGENIC DIET ON MITOCHONDRIAL FUNCTION IN PORCINE PRECISION-CUT KIDNEY SLICES | Lydia Annick Van Furth | Received |
POS-193 | EVALUATION OF SEX DIFFERENCES IN ACUTE KIDNEY INJURY AFTER BD USING AN ISOLATED PERFUSED RAT KIDNEY MODEL | Roberto Armstrong-Jr | Received |
POS-194 | CONTROLLED OXYGENATED REWARMING PROTECTS MITOCHONDRIAL FUNCTION IN DCD PORCINE RENAL GRAFTS. | Hristo Zlatev | Received |
POS-195 | INFRARED THERMAL IMAGING: A NON-INVASIVE, REAL-TIME, BIOMARKER FOR PREDICTING EARLY GRAFT FUNCTION IN KIDNEY TRANSPLANTATION | Dilan Dabare | Received |
POS-196 | COMPARISON OF EARLY POSTTRANSPLANT OUTCOMES IN KIDNEYS PRESERVED BY HYPOTHERMIA MACHINE PERFUSION AND STATIC COLD STORAGE | Janis Jushinskis | Received |
POS-197 | IS VITAMIN D DEFICIENCY RELATED TO REJECTION AND CHRONIC ALLOGRAFT NEPHROPATHY? | Sanem Cimen | Received |
POS-198 | IMPACT OF STRUCTURED DIABETES EDUCATION ON SELF-CARE DIABETES MANAGEMENT OF KIDNEY TRANSPLANTS WITH POST-TRANSPLANT DIABETES: KUWAIT EXPERIENCE | osama Gheith | Received |
POS-199 | T- CELLS COMMANDS CHIEF ORCHESTRAS FOR POST-TRANSPLANT DIABETES | osama Gheith | Received |
POS-200 | EFFECT OF PHYSICAL ACTIVITY AND LIFESTYLE CHANGES ON INSULIN RESISTANCE IN PATIENTS AFTER KIDNEY TRANSPLANTATION | Karol Gra&328;ák | Received |
POS-201 | EFFECT OF STRUCTURED DIABETES EDUCATION ON DIABETIC ANGIOPATHIES AMONG KIDNEY TRANSPLANTS WITH POST-TRANSPLANT DIABETES: KUWAIT EXPERIENCE | osama Gheith | Received |
POS-202 | FLUDROCORTISONE AMONG RENAL TRANSPLANT RECIPIENTS WITH PERSISTENT HYPERKALEMIA: SINGLE CENTER EXPERIENCE. | Mohamed Zahab | Received |
POS-203 | DETERMINANTS OF SECONDARY HYPERPARATHYROIDISM RESOLUTION AFTER KIDNEY TRANSPLANTATION. | Maria Smyrli | Received |
POS-204 | THYROTOXICOSIS AFTER KIDNEY TRANSPLANT: AN EARLY POST-OPERATIVE COMPLICATION | Francesca Ferrara | Received |
POS-206 | SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS (SGLT2I) SHORT-TERM OUTCOME IN DIABETIC KIDNEY TRANSPLANT RECIPIENTS | Jude Yagan | Received |
POS-208 | HIGHER OBESITY CLASSES (II/III) ARE ASSOCIATED WITH INCREASED PERI-OPERATIVE SURGICAL COMPLICATIONS IN KIDNEY TRANSPLANT RECIPIENTS. | Chukwugozie Chukwuenweniwe | Received |
POS-209 | FUNCTIONAL OUTCOMES OF END-ISCHEMIC HYPOTHERMIC MACHINE PERFUSION. | Mercedes Ruiz Hernández | Received |
POS-210 | DELAYED MACHINE-PERFUSED KIDNEY IMPLANTATION IN COMBINED LIVER AND KIDNEY TRANSPLANT: EARLY SINGLE CENTER EXPERIENCE. | Andrea Lauterio | Received |
POS-213 | CLINICAL EFFICACY OF DUAL-KIDNEY TRANSPLANTATION FROM PEDIATRIC DONORS TO ADULT RECIPIENTS | Mingchuan Huang | Received |
POS-214 | ASSESSMENT OF CYSTINOSIS IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS: CASE CONTROL STUDY FROM KUWAIT | osama Gheith | Received |
POS-215 | LOVER URINARY TRACT DYSFUNCTION AND TRANSPLANTATION OUTCOME:A SINGLE CENTER EXPERIENCE | hakan sozen | Received |
POS-217 | A THIRD OF CHILDREN AND THEIR FAMILIES HAD SIGNIFICANT FEAR ABOUT RENAL TRANSPLANTATION DURING THE COVID PANDEMIC | Alicia Paessler | Received |
POS-218 | KIDNEY TRANSPLANTED PATIENTS FROM PEDIATRIC TO ADULT TRANSPLANT CENTRE: TRANSITION DIFFICULTIES AND MANAGEMENT | Francesca Tinti | Received |
POS-219 | COMPLEX BENCH SURGERY DID NOT INCREASE THE RISK OF VASCULAR COMPLICATIONS AFTER PEDIATRIC KIDNEY TRANSPLANTATION | Filippo Ghidini | Received |
POS-220 | UTILISING THE HEMIAZYGOS VENOUS SYSTEM IN LIVING AND DECEASED DONOR PAEDIATRIC KIDNEY TRANSPLANTATION | Sergio Assia-Zamora | Received |
POS-224 | RENAL TRANSPLANTATION IN HUMAN IMMUNODEFICIENCY VIRUS (HIV)-INFECTED PATIENTS | Marta Santiago González | Received |
POS-225 | KIDNEY TRANSPLANTATION DURING THE COVID-19 PANDEMIC PERIOD: A SINGLE CENTER EXPERIENCE | Emre KARAKAYA | Received |
POS-227 | INFLUENCE OF DIFFERENT TRENDS ON RESULTS OF KIDNEY TRANSPLANTS AT A SINGLE CENTER | Victor Denisov | Received |
POS-228 | CHILDBIRTH AFTER KIDNEY TRANSPLANTATION COMPARING DIFFERENT DECADES IN THE HISTORY OF OUR UNIT. BUDAPEST EXPERIENCE | Anna Zsófia Meltzer | Received |
POS-229 | DIGITAL MATURITY OF UNITED KINGDOM RENAL TRANSPLANT CENTRES | Videha Sharma | Received |
POS-230 | EXERCISE INTERVENTIONS IN RENAL TRANSPLANT PATIENTS: A FULL REVIEW | Ilias Marios Oikonomou | Received |
POS-231 | PROTECTING SURGICAL PATIENTS DURING THE COVID-19 PANDEMIC; ADVANTAGES FROM THE ESTABLISHMENT OF A REGIONAL CLINICAL NETWORK | Richard Dumbill | Received |
POS-232 | A SINGLE-CENTER ANALYSIS OF UNPLANNED HOSPITAL READMISSIONS AFTER KIDNEY TRANSPLANTATION: INCIDENCE, CAUSES AND RISK FACTORS | Tlili Syrine | Received |
POS-233 | EMOTIONAL INTELLIGENCE, PSYCHOPATHOLOGY, AND THERAPEUTIC ADHERENCE IN KIDNEY TRANSPLANTATION DURING COVID-19 | Maria Luisa Pistorio | Received |
POS-234 | Timing and duration of pre-transplant screening: is there room for improvement? | Marie Dirix | Received |
POS-235 | COUNSELLING ON CONCEIVING: CONSIDERATIONS OF PROFESSIONALS IN TRANSPLANTATION | Marleen van Buren | Received |
POS-236 | ENHANCED RECOVERY AFTER SURGERY AFTER KIDNEY TRANSPLANTATION: FEASIBILITY AND PREDICTIVE FACTORS IN THE ERA OF EXTENDED CRITERIA DONORS. | Marco Pellicciaro | Received |
POS-237 | SUBJECTIVE CHANGES IN LOWER URINARY TRACT SYMPTOMS AFTER RENAL TRANSPLANTATION | Joanna Chorbi&324;ska | Received |
POS-238 | ADHERENCE AND PATIENTS ATTITUDE TO IMMUNOSUPPRESSIVE THERAPY AFTER KIDNEY TRANSPLANTATION | Fernanda Ortiz | Received |
POS-239 | ESTABLISHING A KIDNEY- PANCREAS TRANSPLANTATION CENTER IN SRI-LANKA- SUPPORTED BY THE ISN-TTS SISTER TRANSPLANT PROGRAM | Entela Kondi | Received |
POS-240 | CONSOLIDATION OF KIDNEY TRANSPLANT PROGRAM IN THE REGION OF MINDANAO (PHILIPPINES) UNDER ISN SISTER RENAL CENTER (SRC) PROGRAM. 5 YEARS EXPERIENCE. | Chlo Ballesté | Received |
POS-241 | DONOR BLOOD TYPE O IS A RISK FACTOR FOR BK POLYOMA VIREMIA IN KIDNEY TRANSPLANT RECIPIENTS | Ruth Rahamimov | Received |
POS-242 | TRANSPLANT IN TIMES OF A SARS-COV2 PANDEMIC, EXPERIENCE IN REFERENCE CENTER PUBLIC HOSPITAL IN MEXICO | Luis Garcia Covarrubias | Received |
POS-247 | RAPID VS. LATE RE-TRANSPLANTATION FOR EARLY KIDNEY GRAFT LOSS | Diana Rodríguez Espinosa | Received |
POS-248 | GENE EXPRESSION ANALYSIS USING QRT-PCR IN THE DIAGNOSIS OF ANTIBODY-MEDIATED REJECTION IN RENAL TRANSPLANT BIOPSIES | Frederic Toulza | Received |
POS-249 | IMPACT OF DE NOVO DONOR SPECIFIC ANTIBODY ACCORDING TO THE TRANSPLANT TYPE IN KIDNEY TRANSPLANTATION | Woo Yeong Park | Received |
POS-250 | PRE-TRANSPLANT DONOR-REACTIVE IL-21 PRODUCING T CELLS CAN HELP PREDICT PATIENTS AT RISK FOR ACUTE REJECTION | Aleixandra Mendoza Rojas | Received |
POS-251 | TOCILIZUMAB IN THE TREATMENT OF ACTIVE CHRONIC HUMORAL REJECTION RESISTANT TO STANDARD THERAPY | Betty Chamoun Huacón | Received |
POS-252 | CD68 URINARY CELLS AS A SURROGATE MARKER OF REJECTION IN KIDNEY TRANSPLANTATION AND CLINICAL-PATHOLOGICAL CORRELATION | Francesca Gervasi | Received |
POS-253 | BIOPSY FINDINGS AFTER DETECTION OF DE NOVO DONOR-SPECIFIC ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS - A SINGLE CENTER EXPERIENCE | Christoph Waldecker | Received |
POS-254 | TOCILIZUMAB TREATMENT IN DSA POSITIVE ANTIBODY MEDIATED REJECTION AMONG KIDNEY TRANSPLANT RECIPIENTS | Orsolya Cseprekal | Received |
POS-255 | CD56BRIGHT CD16DIM NK CELLS PRESENT INCREASED PHENOTYPIC ACTIVATION AND PRO-INFLAMMATORY CYTOKINE SECRETION DURING KIDNEY REJECTION | Elodie Bailly | Received |
POS-259 | ROBOTIC LIVING-DONOR KIDNEY HARVESTING. DOES LONGER WARM ISCHEMIC TIME AFFECT THE TRANSPLANT OUTCOME? | Alessandro Giacomoni | Received |
POS-260 | ANALYSIS OF RISK FACTORS AND LONG-TERM OUTCOMES IN KIDNEY TRANSPLANT PATIENTS WITH IDENTIFIED LYMPHOCELES | Tlili Syrine | Received |
POS-261 | RETROSPECTIVE AND DESCRIPTIVE STUDY OF INCISIONAL HERNIA PREVALENCE ON KIDNEY TRANSPLANT AND RISK FACTORS ASSOCIATED. | Jose Antonio López Plaza | Received |
POS-263 | ROUTINE ULTRASOUND FOLLOWING TRANSPLANT URETERIC STENT REMOVAL DOES IT ALTER PATIENT MANAGEMENT? | Bynvant Sandhu | Received |
POS-264 | IMPACT OF PREOPERATIVE ABDOMINAL ADIPOSE TISSUE ON SURGICAL COMPLICATIONS AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION | Yang Xu | Received |
POS-265 | PRETRANSPLANT MANAGEMENT OF PATIENTS WITH POLYCYSTIC KIDNEY DISEASE | Vasilii Dayneko | Received |
POS-266 | USE OF BOVINE PERICARDIAL PATCH IN LIVING AND DECEASED DONOR KIDNEY TRANSPLANTATION: A SINGLE-CENTER EXPERIENCE ON 14 ARTERIAL RECONSTRUCTIONS. | Maurizio Iaria | Received |
POS-269 | INNATE IMMUNE INTERACTION WITH REENDOTHELIZED VEIN SCAFFOLDS | Yvette Den Hartog | Received |
POS-271 | MALIGNANCY AFTER RENAL TRANSPLANTATION, AN ENTITY THAT MUST KEEP EXPERTS ALERT. | Konstantinos Botsakis | Received |
POS-272 | MALIGNANCY AFTER KIDNEY TRANSPLANTATION - A SINGLE CENTRE OBSERVATIONAL STUDY | Luisa Costa | Received |
POS-273 | ASSOCIATION OF SKIN CANCER WITH THE USE OF MYCOPHENOLATE OR AZATHIOPRINE IN RENAL TRANSPLANT | Gauri Shankar Jagadesh | Received |
POS-274 | DONOR-TRANSMITTED MELANOMA THE NEED FOR CONTINUOUSLY UPDATED GUIDELINES | Christopher Seet | Received |
POS-275 | IMBALANCE OF RESOURCES, AN HYPOTHESIS FOR A NEW WAY OF ALLOCATING LIVERS NOT USED IN THE DONATION REGION | Silvia Trapani | Received |
POS-276 | EVOLUTION OF WAITING LIST FOR LIVER TRANSPLANTATION OVER 20 YEARS IN ONE SINGLE CENTRE IN ROMANIA | Speranta Iacob | Received |
POS-277 | LIVER TRANSPLANTATION FOR T2 HEPATOCELLULAR CARCINOMA IN THE COVID-19 PANDEMIC: A NEW MODEL BALANCING INDIVIDUAL BENEFIT AGAINST HEALTHCARE RESOURCES | Alessandro Vitale | Received |
POS-278 | LIVER TRANSPLANTATION IN THE ELDERLY: PROPOSAL FOR AN INNOVATIVE PATIENT SELECTION PROTOCOL | Alessandro Furlanetto | Received |
POS-279 | MODIFICATION OF DROP-OUT RATES AFTER FOUR YEARS FROM ITALIAN SCORE FOR ORGAN ALLOCATION INTRODUCTION AT A SINGLE CENTRE: A COMPETING RISK ANALYSIS. | Enrico Prosperi | Received |
POS-281 | EVALUATING THE EFFICIENCY OF A NATIONAL ADAPTIVE ALLOCATION SCORING SYSTEM FOR LIVER TRANSPLANTATION: A PRELIMINARY BENCHMARKING ANALYSIS. | Silvia Trapani | Received |
POS-282 | LIVER TRANSPLANTATION IN PATIENTS 70 YEARS RESULTS IN GOOD LONG-TERM OUTCOME - A EUROTRANSPLANT REGISTRY ANALYSIS | Alexander Tyercha | Received |
POS-284 | PROTEOMICS IN LIVER TRANSPLANTATION: BIOMARKERS BEYOND GENOMICS. A SYSTEMATIC REVIEW. | Victor López López | Received |
POS-285 | C-REACTIVE PROTEIN AND UREA BLOOD LEVELS DISTINGUISH PRIMARY NON-FUNCTION FROM EARLY ALLOGRAFT DYSFUNCTION AFTER LIVER TRANSPLANTATION | James Halle-Smith | Received |
POS-286 | PROGNOSTIC VALUE OF PIVKA-II LABELLING IN LESIONS OF HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION | Suzanne Chabert | Received |
POS-289 | DONOR CHARACTERISTICS CAN BE PREDICTIVE OF THE HEPATIC ARTERY THROMBOSIS IN LIVER TRANSPLANTATION | Marco Maria Pascale | Received |
POS-290 | LIVER TRANSPLANTATION AND ISCHEMIC CARDIOPATHY: OUTCOMES OF PRE-TRANSPLANT CORONARY STENTING | Paolo Magistri | Received |
POS-291 | CLINICAL APPLICATION OF EXTRACORPOREAL PHOTOPHERESIS AS AN ALTERNATIVE STRATEGY IN POSTTRANSPLANT IMMUNOSUPPRESSIVE THERAPY | Sergey Korotkov | Received |
POS-292 | MULTICENTRIC DONOR SURVEY 20 YEARS AFTER DONOR HEPATECTOMY | Oya M. Andacoglu | Received |
POS-293 | SIMILAR POST-TRANSPLANT OUTCOMES USING DONORS AFTER CARDIAC DEATH WHEN APPLYING STRICT SELECTION CRITERIA | Margarita Fernández de la Varga | Received |
POS-294 | COMPARISON OF ANTE-MORTEM VS POST-MORTEM CANNULATION IN LIVER DONATION AFTER CIRCULATORY DETERMINATION OF DEATH | Gabriel Moreno-Gonzalez | Received |
POS-295 | PROSPECTIVE HISTOLOGICAL ANALYSIS OF DONOR AND RECIPIENTS HEPATIC ARTERY IN LIVER TRANSPLANTATION. | Ivan Vella | Received |
POS-296 | ERG IN SITU EXPRESSION AS A MARKER OF ENDOTHELIAL STRESS IN EXTENDED CRITERIA DONORS BEFORE AND AFTER GRAFT REPERFUSION. | Francesco Vasuri | Received |
POS-297 | EXTRAHEPATIC MANIFESTATIONS IN PATIENTS WITH LIVER TRANSPLANTATION DUE TO AUTOIMMUNE LIVER DISEASE | Gema Vázquez Contreras | Received |
POS-298 | PERIPHERAL BLOOD TREG:TH17 RATIO IN LIVER TRANSPLANT RECIPIENTS WITH ACUTE REJECTION: ASSESSMENT UTILIZING MAXPAR IMMUNE PROFILING ASSAY. | Angus Hann | Received |
POS-299 | MUSEKAL - A MULTI-CENTRE NON-INTERVENTIONAL STUDY TO ASSESS THE TOLERABILITY AND EFFECTIVENESS OF ENVARSUS IN DE NOVO LIVER TRANSPLANT PATIENTS | Gabriela Berlakovich | Received |
POS-300 | MELTDOSE TECHNOLOGY PROLONGED RELEASE TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: MID-TERM EVALUATION OF THE SAFETY AND EFFICACY | Fabio Melandro | Received |
POS-301 | DIFFERENT EFFECTS OF TACROLIMUS, MYCOPHENOLATE MOFETIL AND RAPAMYCIN ON APOPTOSIS IN HUMAN HEPATOCYTES CULTURES | Razvan Iacob | Received |
POS-302 | IMPACT OF SARS-COV-2 PANDEMIC ON TRANSPLANTATION ACTIVITY IN ITALY: THE REPORTING AT THE END OF THE YEAR | Silvia Trapani | Received |
POS-303 | PNEUMOCYSTIS JIROVECII PNEUMONIA IN LIVER TRANSPLANT RECIPIENTS IN AN ERA OF ROUTINE PROPHYLAXIS | Philip Andreasen | Received |
POS-305 | TENOFOVIR ALAFENAMIDE FOR HEPATITIS B VIRUS PROPHYLAXIS POST-LIVER TRANSPLANTATION: A REAL-WORLD STUDY IN PATIENTS WITH CHRONIC KIDNEY DISEASE | Emmanouil Sinakos | Received |
POS-308 | LIVER TRANSPLANTATION RESULTS IN THE ERA OF MODERN ANTIVIRAL THERAPY OF HEPATITIS C | Kseniia Kokina | Received |
POS-309 | INFLUENZA IN LIVER TRANSPLANT RECIPIENTS: INCIDENCE AND OUTCOMES | Nicoline Stender Arentoft | Received |
POS-310 | EARLY LIVER GRAFT DYSFUNCTION IS A RISK FACTOR FOR A RELAPAROTOMY FOR HEMOPERITONEUM (WITH NO APPARENT SOURCE OF BLEEDING). | Denis Efimov | Received |
POS-312 | LIVER GRAFTS FROM CONTROLLED AND UNCONTROLLED DONATION AFTER CIRCULATORY DEATH IN ITALY: PRESERVATION PROTOCOL AND RESULTS | Riccardo De Carlis | Received |
POS-315 | PERIOPERATIVE RISK FACTORS OF ACUTE KIDNEY INJURY POST LIVER TRANSPLANTATION: A MONOCENTRIC RETROSPECTIVE COHORT STUDY OF 260 PATIENTS | Clarisse Malisoux | Received |
POS-316 | EX-VIVO LIVER SPLITTING DURING HYPOTHERMIC OXYGENATED PERFUSION : A NOVEL PROCEDURE TO OPTIMIZE GRAFT PRESERVATION IN SPLIT LIVER TRANSPLANTATION | Guillaume Rossignol | Received |
POS-318 | IL-6 LEVEL AFTER LIVER TRANSPLANTATION IN PATIENTS DEVELOPING ACUTE KIDNEY INJURY | Francesca Tinti | Received |
POS-319 | PROTECTION OF MITOCHONDRIAL MACHINERY IN HYPOTHERMIC STATIC ISCHEMIA PRESERVATION: A ROLE FOR IGL2 SOLUTION | ARNAU PANISELLO ROSELLO | Received |
POS-320 | IGL2: A SOLUTION FOR LIVER HYPOTHERMIC OXYGENATED PERFUSION (HOPE) STRATEGIES. | ARNAU PANISELLO ROSELLO | Received |
POS-321 | THE RELEASE OF EXTRACELLULAR VESICLES DURING LIVER NORMOTHERMIC MACHINE PERFUSION: A POTENTIAL SOURCE OF VIABILITY MARKERS | Nicholas Gilbo | Received |
POS-322 | CALL FOR AN INTERNATIONAL STUDY TO IDENTIFY TRAJECTORIES TO EARLY ALLOGRAFT FAILURE AND ASSESS HOW EARLY RETRANSPLANT MAY IMPACT ON PATIENT SURVIVAL | giovanni moschetta | Received |
POS-323 | PROLONGED COLD STORAGE PRIOR TO NORMOTHERMIC MACHINE PERFUSION ALTERS THE MOLECULAR PROFILE OF DONOR LIVERS: INSIGHTS FROM BACK TO BASE LIVER NMP. | Fungai Dengu | Received |
POS-324 | INTRODUCING NORMOTHERMIC MACHINE PERFUSION (ORGANOX) INTO CLINICAL PRACTICE THE EDINBURGH EXPERIENCE | Chris Johnston | Received |
POS-326 | EX SITU ISCHAEMIA REPERFUSION MOBILISES PASSENGER LEUKOCYTES INTO THE CIRCUIT DURING LIVER NORMOTHERMIC MACHINE PERFUSION. | Fungai Dengu | Received |
POS-327 | NO DIFFERENCE IN OUTCOMES OF LIVER TRANSPLANTATION USING ELDERLY DONOR GRAFTS VERSUS YOUNG DONOR GRAFTS IN THE SETTING OF SHORT COLD ISCHEMIA TIMES | Miran Bezjak | Received |
POS-328 | POST-TRANSPLANT DIABETES PREDICTS SOLID EXTRA-HEPATIC NON-SKIN CANCER IN LIVER TRANSPLANT RECIPIENTS: A LONG-TERM FOLLOW-UP STUDY | Paolo Magistri | Received |
POS-329 | DIABETES MELLITUS AND PRE-DIABETES IN PRE-LIVER TRANSPLANT PATIENTS: PREVALENCE AND CHARACTERISTICS | Lorella Marselli | Received |
POS-330 | TACROLIMUS BLOOD-BILE RATIO FOR THE EARLY DETECTION OF THE REJECTION GRAFT INJURY AFTER LIVER TRANSPLANTATION | Marco Maria Pascale | Received |
POS-331 | IN-HOSPITAL GLYCEMIC CONTROL AFTER LIVER TRANSPLANTATION: CIRCADIAN HYPERGLYCEMIC DERANGEMENTS. | Glenn Veldscholte | Received |
POS-332 | HETEROGENEOUS INDICATIONS AND THE NEED FOR VIABILITY ASSESSMENT: RESULTS OF AN INTERNATIONAL SURVEY ON MACHINE PERFUSION IN LIVER TRANSPLANTATION | Davide Cussa | Received |
POS-333 | 2,4-DINITROPHENOL TREATMENT DURING NORMOTHERMIC MACHINE PERFUSION OF STEATOTIC HUMAN LIVERS; PHARMACOLOGICAL CONSIDERATIONS IN PERFUSION | Samuel Tingle | Received |
POS-334 | A MATCHED COMPARISON OF HYPOTHERMIC OXYGENATED MACHINE PERFUSION VS. COLD STORAGE IN LIVER TRANSPLANTATION | Franziskus Horodynski | Received |
POS-335 | HYPOTHERMIC OXYGENATED PERFUSION OF LIVER GRAFTS: A COST ANALYSIS | Stefania Camagni | Received |
POS-336 | ROLE OF D-HOPE RECONDITIONING OF LIVER GRAFTS FROM EXTENDED CRITERIA DBD DONORS | Paolo Magistri | Received |
POS-338 | ASSESSMENT OF MITOCHONDRIAL FUNCTION DURING PROLONGED EX VIVO LIVER NORMOTHERMIC MACHINE PERFUSION | Julia Hofmann | Received |
POS-341 | MEDICATION NON-ADHERENCE PREVALENCE AND DETERMINANTS IN CHILDREN AND ADOLESCENTS WITH CHRONIC LIVER DISEASES | Amirali Mashhadiagha | Received |
POS-342 | ARTERIAL AND BILIARY COMPLICATIONS AFTER LIVER TRANSPLANTATION A SINGLE CENTER STUDY | Cristina Radu | Received |
POS-343 | INFLUENCE OF COVID19 PANDEMIC ON RECENTLY OPENED LIVER TRANSPLANTATION PROGRAMME IN GDANSK | Dariusz Laski | Received |
POS-345 | IS THERE A ROLE FOR INTENSIVE CARE IN LIVER TRANSPLANT ASSESSMENT? | Dhupal Patel | Received |
POS-347 | TREATMENT OF HEPATIC ARTERY OBSTRUCTION: THE LESSONS LEARNED IN A SERIES OF 2,478 LIVER TRANSPLANTS | fabio melandro | Received |
POS-348 | EARLY POST-OPERATIVE ANALGESIA FOLLOWING LIVER TRANSPLANT | Arturs Fedotovs | Received |
POS-349 | IS EARLY EXTUBATION AFTER LIVER TRANSPLANTATION FEASIBLE? | Sapna Sharma Hajela | Received |
POS-350 | IS ULTRASOUND AN UNNECESSARY BARRIER TO EARLY EXTUBATION AFTER LIVER TRANSPLANTATION? | Anna Shahid | Received |
POS-351 | PROXIMAL SPLENIC ARTERY EMBOLIZATION FOR REFRACTORY ASCITES AND HYDROTHORAX AFTER LIVER TRANSPLANT: A SINGLE CENTER EXPERIENCE | Luca Del Prete | Received |
POS-352 | LIVER TRANSPLANTATION FOR COVID-19-ASSOCIATED CHOLANGIOPATHY | Joris Blondeel | Received |
POS-353 | LDLT DURING COVID -19 PANDEMIC IN A SINGLE ROMANIAN TERTIARY REFERRAL CENTRE | Gabriela Smira | Received |
POS-356 | LIVER TRANSPLANTATION AND THE SEVENTH DAY SYNDROME: A SYSTEMATIC REVIEW OF THE LITERATURE AND CASE SERIES. | James Halle-Smith | Received |
POS-357 | AN ITALIAN SURVEY ON THE USE OF T-TUBE IN LIVER TRANSPLANTATION | Riccardo Pravisani | Received |
POS-359 | THE EFFECT OF PORTAL HYPERTENSION IN INTRAOPERATIVE BLEEDING DURING LIVER TRANSPLANTATION | Josep Martí Sanahuja Blasco | Received |
POS-360 | THE INFLUENCE OF SELECTED CRITERIA ON THE BILIARY COMPLICATIONS OCCURENCE | Katarzyna Biernat | Received |
POS-361 | PORTAL VEIN THROMBOSIS AND LIVER TRANSPLANTATION: RESULTS OF THE ITALIAN SOCIETY OF ORGAN TRANSPLANTATION NATIONAL SURVEY | Paolo Magistri | Received |
POS-362 | A PILOT STUDY OF A NON-INVASIVE REAL-TIME OPTICAL BACKSCATTER PROBE IN LIVER TRANSPLANTATION | James Richards | Received |
POS-364 | THE CHALLENGING MANAGEMENT OF VASCULAR RECONSTRUCTION IN LIVING DONOR LIVER TRANSPLANTATION THROUGH THE RECENT EXPERIENCE OF THE MODENA UNIVERSITY | Stefano Di Sandro | Received |
POS-365 | LIVER TRANSPLANT EXPERIENCES FOR THE BUDD-CHIARI SYNDROME AT BASKENT UNIVERSITY TRANSPLANT CENTERS | Emre KARAKAYA | Received |
POS-366 | CLINICAL OUTCOMES OF LIVER TRANSPLANTATION FOR PATIENTS OVER 60 YEARS OLD; A SINGLE CENTER EXPERIENCE | Aydincan Akdur | Received |
POS-367 | CAVOPORTAL HEMITRANSPOSITION ASSOCIATED TO PORTOPORTAL ANASTOMOSIS FOR LIVER TRANSPLANT IN PORTOMESENTERIC THROMBOSIS: HOW WE DO IT | Eugenia Rosso | Received |
POS-368 | LAPAROSCOPIC VS. LAPAROTOMIC LEFT LATERAL SECTIONECTOMY IN PEDIATRIC LIVING DONOR LIVER TRANSPLANTATION | Sara Maritato | Received |
POS-370 | TECHNICAL REFINEMENTS TO THE RAPID TECHNIQUE: A POTENTIAL BREAKTHROUGH IN TRANSPLANT ONCOLOGY | Eugenia Rosso | Received |
POS-373 | POSTOPERATIVE TRENDS AND PROGNOSTIC VALUES OF INFLAMMATORY AND NUTRITIONAL BIOMARKERS AFTER LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA | Riccardo Pravisani | Received |
POS-374 | MELDING LOCOREGIONAL TREATMENT OF HEPATOCELLULAR CARCINOMA (HCC) INTO LIVER TRANSPLANTATION PROGRAMME AT NEWLY FOUNDED CENTRE. | Krzysztof Graff | Received |
POS-375 | MODIFYING THE RETREAT SCORE TO PREDICT RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION | Monique Devillers | Received |
POS-377 | COMPLETE RESPONSE AFTER BIOLOGICAL DOWNSTAGING IN HEPATOCELLULAR CARCINOMA: XXL-LIKE PRIORITIZATION FOR TRANSPLANTATION OR WAITING AND SEE STRATEGY? | Alessandro Vitale | Received |
POS-378 | DE NOVO MALIGNANCY FOLLOWING LIVING DONOR LIVER TRANSPLANTATION: A SINGLE CENTER EXPERIENCE | Kohei Miura | Received |
POS-379 | ROBOTIC LIVER RESECTION FOR HCC AS A BRIDGE TO TRANSPLANTATION | Paolo Magistri | Received |
POS-380 | LONG-TERM OUTCOMES OF DE NOVO MALIGNANCY AFTER LIVER TRANSPLANTATION FOR ALCOHOLIC CIRRHOSIS | Marco Maria Pascale | Received |
POS-381 | IMMUNE CHECKPOINT AND IMMUNE CELL EXPRESSION IN THE TUMOR MICROENVIROMENT OF RESECTED HCC | Angeles Baquerizo | Received |
POS-384 | LIVER TRANSPLANTATION FOR METASTATIC NEUROENDOCRINE TUMORS: TIME TO EXTEND CRITERIA? | Marianna Maspero | Received |
POS-385 | DOWN-STAGING TREATMENT IMPROVEMENTS CHANGED THE PARADIGM OF LIVER TRANSPLANTATION FOR HCC | Enrico Prosperi | Received |
POS-386 | LIVER TRANSPLANTATION FOR HCC IN HIV PATIENTS: SINGLE CENTER EXPERIENCE | Marco Angelo Bongini | Received |
POS-387 | A RETROSPECTIVE SINGLE-CENTER ANALYSIS OF THE ONCOLOGICAL IMPACT OF LI-RADS CLASSIFICATION APPLIED TO METROTICKET 2.0 CALCULATOR: EVERY NODULE MATTERS | Leonardo Centonze | Received |
POS-389 | NEW STRATEGIES FOR THE MANAGEMENT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA AFTER COVID-19 PANDEMIC: A PROPOSAL FOR A NEW READY TO USE APP | Dario Quintini | Received |
POS-390 | THE IMPACT OF IMAGING AND PRE-TRANSPLANT TREATMENTS ON LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA | Daniele Dondossola | Received |
POS-391 | DOES NASH JEOPARDIZE LIVER TRANSPLANT SURVIVAL IN HCC PATIENTS? THE NIGUARDA EXPERIENCE | Fabio Ferla | Received |
POS-392 | TRANSPLANT BENEFIT AND URGENCY IN LUNG TRANSPLANTATION | Daniela Peritore | Received |
POS-393 | EXTRA-CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM EXCHANGES IN SARS-COV-2 PATIENTS AWAITING LUNG TRANSPLANT: LARGEST CASE SERIES FROM INDIA. | Vijil Rahulan | Received |
POS-395 | TOLERANCE OF ANTI-CMV PROPHYLAXIS WITH VALGANCICLOVIR ONE-YEAR TREATMENT IN D/R- LUNG TRANSPLANT PATIENTS. A SINGLE-CENTER RETROSPECTIVE STUDY | charlotte roy | Received |
POS-396 | A RANDOMIZED, MULTICENTER, BLINDED STUDY ASSESSING THE EFFECTS OF GASEOUS NITRIC OXIDE IN AN EX VIVO SYSTEM OF HUMAN LUNGS | Dana Torchia | Received |
POS-397 | LUNG BIOMOLECULAR PROFILE AND FUNCTION COMPARING GRAFT FROM MARGINAL BRAIN-DEAD DONORS AND DONORS AFTER CARDIAC DEATH | Jacopo Fumagalli | Received |
POS-398 | FEMALE RATS PRESENT HIGHER LUNG INFLAMMATION AFTER BRAIN DEATH FOLLOWED BY EX VIVO PERFUSION | Fernanda Yamamoto Ricardo da Silva | Received |
POS-399 | DONATION AFTER CARDIAC DEATH: A PERSPECTIVE FOR PEDIATRIC LUNG TRANSPLANTATION | Francesca Melosi | Received |
POS-400 | EFFECTS OF AZITHROMYCIN IN LUNG TRANSPLANT RECIPIENTS | Valeria Rossetti | Received |
POS-401 | SARS-COV-2 POSITIVE DONORS FROM NON-SUITABILITY TO THE USE FOR ORGAN TRANSPLANTATION | Federica Domini | Received |
POS-402 | UNINTERRUPTED AND SUCCESSFUL DECEASED PROGRAMME DURING THE COVID-19 CRISIS IN SLOVENIA | imenc Jana | Received |
POS-403 | INNATE INFLAMMATORY GENE EXPRESSION PROFILING IN POTENTIAL BRAIN-DEAD DONORS: DETAILED INVESTIGATION OF THE EFFECT OFCOMMON CORTICOSTEROID THERAPY | Sanaz Dehghani | Received |
POS-404 | NATIONAL DATASET ON DONATION AFTER CIRCULATORY DEATH AND BRAIN DEATH UNDER EXTRA-CORPOREAL SUPPORT: 3-YEAR ACTIVITY AND CRITICAL POINTS | Francesca Vespasiano | Received |
POS-405 | PROTOCOL FOR ORGAN OFFERS FROM ABROAD DURING THE COVID-19 PANDEMIC | Raffaele Donadio | Received |
POS-406 | A SINGLE CENTRE REVIEW OF THE DECEASED DONOR POPULATION IN A CARDIOTHORACIC INTENSIVE CARE OVER A 5 YEAR PERIOD | Aisling Mc Intyre | Received |
POS-407 | INTERNATIONAL REGISTRY IN ORGAN DONATION AND TRANSPLANTATION (IRODAT) 2019 VS 2020 WORLDWIDE DATA OVERVIEW | Marián Irazábal | Received |
POS-408 | ORGAN DONATION INNOVATIVE STRATEGIES FOR SOUTHEAST ASIA: ODISSEA | Maria Gomez | Received |
POS-409 | FIRST ITALIAN EXPERIENCE OF MOBILE ECMO TEAMS FOR CONTROLLED DONATION AFTER CIRCULATORY DEATH | Maria Adele Figini | Received |
POS-410 | LOSS OF SEROPROTECTION IN PATIENTS TRANSPLANTED FROM SOLID ORGANS PREVIOUSLY VACCINATED AGAINST HEPATITIS B | Lejeune Sophie | Received |
POS-411 | INVERTED DIRECT ALLORECOGNITION TRIGGERS EARLY DONOR SPECIFIC ANTIBODY RESPONSE AFTER TRANSPLANTATION | Xavier Charmetant | Received |
POS-412 | THE BLACK BOX OF IMMUNOSUPPRESSION AFTER SOLID ORGAN TRANSPLANTATION | Janne Kaes | Received |
POS-413 | DRUG TRANSPORTERS EXPRESSION IS ASSOCIATED WITH TACROLIMUS INTRACELLULAR CONCENTRATION | Florian Lemaitre | Received |
POS-414 | SMALL MOLECULE BCL6 INHIBITORS: A NEW DRUG CLASS OF IMMUNOSUPPRESSION FOR TRANSPLANTATION? | Louisa Steines | Received |
POS-415 | LACK OF INFORMATION IN RANDOMIZED CONTROLLED TRIALS TO GUIDE TRANSLATION OF MEDICATION ADHERENCE INTERVENTIONS TO CLINICAL PRACTICE: SYSTEMATIC REVIEW | Janette Ribaut | Received |
POS-416 | OUTCOMES OF SARS-COV-2 INFECTION IN PATIENTS UNDER PHARMACOLOGICAL IMMUNOSUPPRESSION: IS THERE ANY ADDITIONAL RISK? A SWISS COHORT STUDY. | Antonio Galante | Received |
POS-418 | FINGERPRICK SAMPLES FOR TACROLIMUS LEVELS DURING THE COVID-19 PANDEMIC: SINGLE CENTRE EXPERIENCE WITH HEART AND LUNG TRANSPLANT RECIPIENTS | Haifa Lyster | Received |
POS-419 | INCIDENCE OF STREPTOCOCCUS PNEUMONIAE AND HEMOPHILUS INFLUENZAE INFECTIONS IN ADULT SOLID ORGAN TRANSPLANT RECIPIENTS | Omid Rezahosseini | Received |
POS-420 | EARLY DETECTION OF EPSTEIN-BARR VIRUS (EBV) IN SOLID ORGAN TRANSPLANT RECIPIENTS. COMPARISON OF PCR FOR EBV DNA IN THREE DIFFERENT BLOOD COMPARTMENTS | Lene Ugilt Pagter Ludvigsen | Received |
POS-421 | THE CLINICAL OUTCOMES OF COVID-19 DISEASE IN PATIENTS WITH SOLID ORGAN TRANSPLANTATION | gaye ulubay | Received |
POS-422 | EVALUATION OF TRANSPLANTS PERFORMED IN ITALY WITH DONOR ORGANS WITH INFECTIOUS AND NEOPLASTIC RISK | Davide Stabile | Received |
POS-424 | IMPACT OF SARS-COV-2 INFECTION IN SOLID ORGAN TRANSPLANT RECIPIENTS: THE REPORTING DATA AT THE END OF A DIFFICULT YEAR IN ITALY. | Silvia Trapani | Received |
POS-425 | THE IMPACT OF TRANSPLANT TYPE, AGE AND IMMUNOSUPPRESSION ON POST COVID-19 INFECTION SURVIVAL: A SINGLE CENTER UNITED STATES PROSPECTIVE COHORT STUDY. | Hailey Hardgrave | Received |
POS-427 | INTEREST IN AND EXPOSURE TO TRANSPLANT SURGERY AMONG MEDICAL STUDENTS AND TRAINEE DOCTORS | Diana Wu | Received |
POS-428 | eHealth delivered interventions for solid organ and hematopoietic stem cell transplantation recipients: A scoping review | Eleni Renaers | Received |
POS-430 | EUROPEAN INITIATIVES IN LIVING ORGAN DONATION PROGRAMS | Entela Kondi | Received |
POS-431 | PERCEPTIONS ON THE COVID-19 VACCINE: A PILOT STUDY | Fernando Yuen Chang | Received |
POS-432 | ORGAN DONATION AND TRANSPLANTATION DURING COVID-19 IN THE UK: CHALLENGES, LESSONS AND OPPORTUNITIES FOR FUTURE | Shivani Sharma | Received |
POS-433 | EVALUATING THE IMPACT OF CLINICAL LEADS FOR UTILISATION IN THE UNITED KINGDOM IN ADDRESSING NATIONAL AND LOCAL BARRIERS TO ORGAN TRANSPLANTATION | John Forsythe | Received |
POS-434 | SURVEY ON REGIONAL INITIATIVES SUPPORTING FOLLOWUP OF TRANSPLANTED PATIENTS DURING SARS-COV-2 PANDEMIC | Alessandra Oliveti | Received |
POS-435 | PILOT OBSERVATIONAL STUDY TO OBTAIN FEEDBACK ON MEDICATION COUNSELLING POST HEART & LUNG TRANSPLANT DURING THE COVID -19 PANDEMIC | Aanchal Grover | Received |
POS-436 | SOLID ORGAN TRANSPLANT RECIPIENTS RISK PERCEPTIONS, SHIELDING BEHAVIOUR AND PUBLIC TRUST DURING THE COVID-19 PANDEMIC | Angus Hann | Received |
POS-437 | T REGULATORY CELLS IN PATHOGENESIS OF CORNEAL GRAFT REJECTION | Justyna Sakowska | Received |
POS-438 | PANCREAS TRANSPLANTATION IN BLACK, ASIAN AND ETHNIC MINORITIES-A SINGLE CENTRE EXPERIENCE IN THE UK | Jeevan Gopal | Received |
POS-440 | WEIGHT GAIN FOLLOWING PANCREAS TRANSPLANTATION IN TYPE 1 DIABETES IS ASSOCIATED WITH A WORSEN GLYCEMIC PROFILE: A RETROSPECTIVE COHORT STUDY | Pedro Ventura Aguiar | Received |
POS-441 | THERE IS NO WEEKEND EFFECT IN PANCREAS TRANSPLANTATION | Ky-Leigh Ang | Received |
POS-442 | PATIENT EXPERIENCE IN PANCREAS TRANSPLANTATION A METHODOLOGICAL APPROACH TOWARDS INNOVATION IN AN ESTABLISHED PROGRAM | Pedro Ventura Aguiar | Received |
POS-443 | HEMOGLOBIN A1C AFTER PANCREAS-KIDNEY TRANSPLANTATION AS A PREDICTIVEMARKER FOR ENDOCRINE FUNCTION FAILURE IN PANCREATIC GRAFTS. | Emanuel Vigia | Received |
POS-444 | ENTERIC CONVERSION AFTER BLADDER-DRAINED KIDNEY-PANCREAS TRANSPLANTATION | Shobana Sivan | Received |
POS-445 | ENTERIC LEAK IN PANCREAS TRANSPLANTATION: COMPARING HAND-SEWN VS STAPLED ENTERIC ANASTOMOSES | Qingwei Zhang | Received |
POS-446 | SURGICAL COMPLICATIONS AFTER PANCREAS TRANSPLANTATION SINGLE CENTRE EXPERIENCE. | Pawel Skrzypek | Received |
POS-450 | DETECTING TISSUE DONORS IN A HOSPITAL EMERGENCY DEPARTMENT DURING COVID-19 PANDEMIC | Nuria Masnou Burralló | Received |
POS-451 | APPROACHING FAMILIES FOR ORGAN DONATION AUTHORISATION: HOW DO WE ASSESS A SOCIAL PROCESS? | Lissette Aviles | Received |
POS-452 | EXPERIENCE OF WELL-BEING AND MENTAL HEALTH AMONG TRANSPLANTED PATIENTS -A SYSTEMATIC LITERATURE REVIEW | Maria Ohm | Received |
POS-453 | IMPROVING IMMUNOSUPPRESSIVE MEDICATION ADHERENCE USING THE MARS-INTERVENTION: CASE STUDY ON ACHIEVING ENGAGEMENT AND ADHERENCE | Denise Beck | Received |
POS-454 | BILATERAL UPPER LIMB TRANSPLANTATION INCLUDING SHOULDER RECONSTRUCTION: Decision-making process and case presentation | Selma LAHLALI | Received |
POS-455 | MULTIFACETED APPROACH FOR DESENSITIZATION OF A HYPERIMMUNE HEART TRANSPLANTATION RECIPIENT | Denise Galbiati | Received |
POS-456 | A CASE OF CARDIAC TRANSPLANT COVID-19 - ASSOCIATED ACUTE MYOCARDITIS | Nadegda Koloskova | Received |
POS-457 | BARIATRIC SURGERY AFTER INTESTINAL TRANSPLANTATION IS SAFE AND EFFECTIVE. | Mathias Clarysse | Received |
POS-458 | NATIVE JEJUNAL CONDUIT FOR URINARY DIVERSION IN EN-BLOC LIVER-INTESTINE-KIDNEY TRANSPLANTATION | Luca Del Prete | Received |
POS-459 | RENAL TRANSPLANTATION IN GIGANTISM-A CASE REPORT AND REVIEW OF THE LITERATURE | Jeevan Gopal | Received |
POS-460 | LIVING-RELATED KIDNEY TRANSPLANTATION IN A PATIENT WITH JUVENILE NEPHRONOPHTHISIS | Ivana Dedinska | Received |
POS-462 | RENAL TRANSPLANTATION FROM A LIVING DONOR WITH RENAL ARTERY FIBROMUSCULAR DYSPLASIA | Paraskevi Andronikidi | Received |
POS-463 | RITUXIMAB IS EFFECTIVE IN TREATING KIDNEY ALLOGRAFT RECURRENT IGA NEPHROPATHY WITH NECROTIZING ARTERIOLITIS: A CASE REPORT | Nattawat Klomjit | Received |
POS-465 | ETANERCEPT-INDUCED LUPUS NEPHRITIS IN A KIDNEY TRANSPLANT RECIPIENT | Ivan Margeta | Received |
POS-466 | AB0 INCOMPATIBLE TRANSPLANTATION IN A PATIENT WITH COMPLEMENT DYSREGULATION: A DELICATE MATTER | Enrico Eugenio Minetti | Received |
POS-467 | DRUG INDUCED PURE RED CELL APLASIA IN RENAL TRANSPLANT RECIPIENT: CASE REPORT AND REVIEW OF LITERATURE. | Ayman Maher | Received |
POS-468 | SYNTHETIC ADRENOCORTICOTROPIC HORMONE A TREATMENT OPTION FOR POST RENAL TRANSPLANT RECURRENT RESISTANT PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS | Gauri Shankar Jagadesh | Received |
POS-469 | BELATACEPT AS MAINTENANCE THERAPEUTIC: AN ANSWER FOR DE NOVO THROMBOTIC MICROANGIOPATHY WITH ACUTE ANTIBODY-MEDIATED REJECTION | Mariana Sousa | Received |
POS-470 | THE FIRST REPORT OF HIV-POSITIVE KIDNEY TRANSPLANTATION IN THAILAND: PROVIDING THE OPPORTUNITY AND ACCESSIBILITY TO TRANPSLANTATION | Suwasin Udomkarnjananun | Received |
POS-471 | DISSEMINATED RHINOCLADIELLA MACKENZIEI INFECTION IN A KIDNEY TRANSPLANT RECIPIENT: CASE REPORT AND LITERATURE REVIEW. | Mohamed Zahab | Received |
POS-472 | SUCCESSFUL LIVE RELATED KIDNEY TRANSPLANT AFTER RECOVERY OF COVID-19 PNEUMONIA: CASE REPOT AND REVIEW OF LITERATURE. | osama Gheith | Received |
POS-475 | FOSCARNET INDUCED GENITAL LESIONS IN A KIDNEY TRANSPLANT RECIPIENT: A CASE REPORT. | Laura Diotallevi | Received |
POS-476 | PULMONARY MUCORMYCOSIS IN A KIDNEY TRANSPLANT RECIPIENT | Zdenek Lys | Received |
POS-477 | SUCCESSFUL TREATMENT OF TYPICAL HEMOLYTIC UREMIC SYNDROME IN A KIDNEY TRANSPLANT RECIPIENT USING ECULIZUMAB AND HAEMOADSORPTION DEVICES | Virginia Pronzo | Received |
POS-478 | STRONGYLOIDES STERCORALIS HYPERINFECTION SYNDROME IN A PATIENT UNDERGOING KIDNEY TRANSPLANT | LAURA LANCIONE | Received |
POS-479 | COVID-19 EARLY AFTER RENAL TRANSPLANTATION: LIMITATIONS AND HAZARDS OF UNPROVEN THERAPIES. | Concetta Cacace | Received |
POS-480 | KINETICS OF LYMPHOCYTE SUBSETS IN A RENAL RECIPIENT WITH CMV DISEASE TREATED WITH GANCYCLOVIR AND ANTI-CMV HYPERIMMUNE INTRAVENOUS IMMUNOGLOBULIN. | Javier Carbone | Received |
POS-481 | HERPES SIMPLEX VÍRUS-2 HEPATITIS FOLLOWING KIDNEY TRANSPLANT: TAKE A SECOND LOOK | Sara Fernandes | Received |
POS-482 | ALTERNARIA ALTERNATA PHAEOHYPHOMYCOSIS POST RENAL TRANSPLANT MASQUERADING AS CUTANEOUS TUMOUR | Laura Clementoni | Received |
POS-483 | MALAKOPLAKIA: A RARE CAUSE OF KIDNEY GRAFT DYSFUNCTION. | Cinthia Baldallo Moreno | Received |
POS-484 | THROMBOTIC MICROANGIOPATHY SECONDARY TO COVID-19 IN A RECENT ABO-INCOMPATIBLE KIDNEY TRANSPLANT RECIPIENT. | Zaira Ivette Castañeda Amado | Received |
POS-485 | IS THERE ANY ROOM FOR A CONSERVATIVE APPROACH FOR A GRAFT ARTERY ANEURISM? | Enrico Eugenio Minetti | Received |
POS-486 | REVERSIBLE ISCHEMIC NEPHROPATHY IN CADAVERIC RENAL TRANSPLANT RECIPIENT | osama Gheith | Received |
POS-487 | TREATMENT OF PSUEDOANEURISM OF EXTERNAL ILIAC ARTERY IN PATIENT UNDERGOING KIDNEY TRANSPLANT | LAURA LANCIONE | Received |
POS-488 | TIGECYCLINE-INDUCED ACUTE PANCREATITIS IN RENAL TRANSPLANT RECIPIENT: CASE REPORT AND REVIEW OF LITERATURE. | Ayman Maher | Received |
POS-489 | TRANSIENT HYPERPHOSPHATASEMIA IN AN ADOLESCENT AND AN ADULT RENAL TRANSPLANT PATIENT | Erasmia Sampani | Received |
POS-490 | A SUCCESSFUL KIDNEY AUTOTRANSPLANTATION IN A PATIENT WITH MULTIPLE RENAL ARTERY ANEURYSMS | Andriy Nykonenko | Received |
POS-491 | EN-BLOC KIDNEY TRANSPLANT USING AN AORTIC EXTENSION FROM A PAEDIATRIC MULTI-VISCERAL DONOR TO A PAEDIATRIC RECIPIENT. | Sergio Assia-Zamora | Received |
POS-492 | IS PREGNANCY SAFE IN THE EN BLOC RENAL RECIPIENTS FROM INFANT DONORS? A CASE REPORT | Zhendi Wang | Received |
POS-493 | WEST NILE ENCEPHALITIS IN AN ADOLESCENT KIDNEY TRANSPLANT RECIPIENT | Nikoleta Printza | Received |
POS-494 | ACQUIRED FACTOR VII DEFICINCY POST RENAL TRANSPLANTATION | Nihal Bashir | Received |
POS-495 | KIDNEY TRANSPLANTATION AS A TREATMENT OF CHOICE FOR AA AMYLOIDOSIS DUE TO PERIODIC FEVER SYNDROME | Ivana Dedinska | Received |
POS-496 | 50TH ANNIVERSARY OF THE FIRST KIDNEY TRANSPLANT IN BELARUS:SUCCESS PROGRAM HIGHLIGHTS AND CURRENT RESULTS | Aleh Kalachyk | Received |
POS-498 | THROW THE HEART OVER THE FENCE: SUCCESSFUL LIVING DONOR KIDNEY TRANSPLANT IN YOUNG MALE WITH SEVERE DISABILITY | Fausta Piancone | Received |
POS-501 | NEVER FORGET YOUR TRANSPLANT SURGERY IT COULD BE A LATE CAUSE OF ALLOGRAFT DYSFUNCTION | Filipa Ferreira | Received |
POS-502 | URETERIC TRAUMA FOLLOWING STENT REMOVAL IN KIDNEY TRANSPLANT RECIPIENT: A UNIQUE CASE OF PROLONGED MORBIDITY | AHMAD MIRZA | Received |
POS-503 | NOVEL MINIMALLY INVASIVE HYBRID APPROACH FOR TRANSPLANT URETERIC STENT EXCHANGES IN THE CONTEXT OF DIFFICULTY ACCESSING THEATRE DURING PANDEMIC | Robert Pearson | Received |
POS-505 | SYMPTOMATIC INCISIONAL HERNIA REPAIR POST KIDNEY TRANSPLANT: A SINGLE CENTRE EXPERIENCE | Laura Clementoni | Received |
POS-506 | RETROPERITONEOSCOPIC HAND-ASSISTED RIGHT NEPHRECTOMY IN LIVE DONOR WITH LEFT-SIDED INFERIOR VENA CAVA: CASE REPORT. | Carmelo Puliatti | Received |
POS-507 | MALIGNANT LYMPHOMA IN LIVING KIDNEY DONOR AND ITS RECIPIENT: THE DIAGNOSIS AFTER TRANSPLANTATION. | Concetta Cacace | Received |
POS-508 | POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD): IS THE SECRET HIDDEN IN THE SPLEEN? | Ana Rodrigues | Received |
POS-509 | MERKELL CELL CARCINOMA AFTER KIDNEY TRANSPLANTATION | Andrea Bruno | Received |
POS-510 | GUILLAIN-BARRE SYNDROME CAUSED BY AN ALLOGRAFT RENAL CELL CANCER | Izabela Zakrocka | Received |
POS-513 | LIVER TRANSPLANTATION AFTER TAVI PREHABILITATION COMPLICATED BY CARDIAC ARREST, PULMONARY EMBOLISM AND STENOSIS OF IVC. | Aliaksei Shcherba | Received |
POS-515 | GRAFT VERSUS HOST DISEASE FOLLOWING LIVER TRANSPLANTATION A CLINICAL CASE | Aliki Xochelli | Received |
POS-516 | THE HIDDEN ENEMY BEHIND COVID-19 IN A RECENT LIVER TRANSPLANT PATIENT | Bianca Magro | Received |
POS-517 | LIVER TRANSPLANTATION IN RECIPIENTS WITH HISTORY OF AIDS-DEFINING CLINICAL CONDITIONS: IS IT POSSIBLE TO EXTEND THE INDICATIONS? | Matteo Ravaioli | Received |
POS-518 | TRANSPLANTATION OF A DISCARDED LIVER AFTER ISCHEMIA-FREE PROCUREMENT | Luca Del Prete | Received |
POS-519 | ATOVAQUONE INDUCED FULMINANT HEPATIC FAILURE IN LIVER TRANSPLANTATION | Virginia Ceccarossi | Received |
POS-520 | PROLONGED QT DURING ANAESTHESIA FOR PEDIATRIC CADAVERIC LIVER TRANSPLANTATION: A CASE REPORT | Ilaria Mascilini | Received |
POS-521 | CONTINUOUS RENAL REPLACEMENT THERAPY IN SMALL PEDIATRIC LIVER TRANSPLANT PATIENTS WITH ACUTE RENAL FAILURE | Dor Yoeli | Received |
POS-522 | APPLICATION OF AMPLTZER CARDIAC PLUG FOR FLOW MODULATION IN POST-TRANSPLANT PORTAL-STEAL SYNDROME FROM A SURGICAL LINTONS SPLENO-RENAL SHUNT | Leonardo Centonze | Received |
POS-523 | A CASE OF LIVER AUTOTRANSPLANTATION FOR GIGANTIC HEMANGIOMA WITH COAGULOPATHY | Ayato Obana | Received |
POS-525 | RESTORATION OF PORTAL INFLOW AFTER CAVOPORTAL HEMITRANSPOSITION IN A LIVER TRANSPLANT RECIPIENT WITH COMPLETE SPLANCHNIC THROMBOSIS | Mathias Clarysse | Received |
POS-526 | INTRALUMINAL BLEEDING FROM JEJUNAL ANASTOMOSIS STOPPED WITH INTRAOPERATIVE HAND ASSISTED ENTEROSCOPYAFTER ORTHOTROPIC LIVER TRANSPLANTATION | Krzysztof Graff | Received |
POS-527 | LIFE-SAVING LEFT RENAL VEIN LIGATION TO INTERRUPT SPONTANEOUS PORTOSYSTEMIC SHUNT AND RESTORE PORTAL VEIN FLOW AFTER SPLIT LIVER TRANSPLANTATION | Ivan Vella | Received |
POS-528 | PORTO-CAVAL SHUNT IN SPLIT LIVER TRANSPLANTATION: IS THERE ANY TIME LIMIT TO CLOSE IT? | Maria Fortuna Offi | Received |
POS-530 | A CASE OF SUCCESSFUL LIVER TRANSPLANTATION FROM DECEASED DONOR WITH BRAIN DEATH IN A PATIENT WITH RANDU-OSLER-WEBER DISEASE | Sergey Korotkov | Received |
POS-531 | LIVER TRANSPLANTATION FOR INTRAHEPATIC MASS-FORMING CHOLANGIOCARCINOMA FOLLOWING NEOADJUVANT CHEMOTHERAPY AND TRANS-HEPATIC RADIOEMBOLIZATION | Marianna Maspero | Received |
POS-532 | THE EFFECT OF PRE-TRANSPLANT LIPID PROFILE ON POST-TRANSPLANT HCC RECURRENCE | Volkan Ince | Received |
POS-534 | STENTING OF PULMONARY VEIN STENOSIS AFTER LOBAR LUNG TRANSPLANTATION: MINIMAL INVASIVE INTERVENTION TO AVOID GRAFT LOSS | Michaela Orlitova | Received |
POS-535 | DONOR-DERIVED TUBERCULOSIS IN LUNG TRANSPLANT RECIPIENT: THE NEED OF DONOR SCREENING | Renato Pascale | Received |
POS-537 | NEPHROTIC SYNDROME DUE TO NODULAR GLOMERULOSCLEROSIS IN A NON-DIABETIC LUNG TRANSPLANT RECIPIENT WITH CYSTIC FIBROSIS | Edith Renoult | Received |
POS-538 | NORMOTHERMIC EX-VIVO LUNG PERFUSION (EVLP) WITH PULMONARY ARTERY (PA) RECONSTRUCTION AFTER ITS MAIN TRUNK ACCIDENTAL DIVISION DURING HARVESTING | Elena Salvaterra | Received |
POS-539 | A LUNG TRANSPLANT PROGRAM SNAPSHOT AT THE TIME OF COVID-19: STILL EMERGENCY CASES FEASIBLE? | Elena Salvaterra | Received |
POS-540 | LUNG TRANSPLANT FOLLOWING COVID-19 INFECTION AFTER 6 MONTHS ON ECMO SUPPORT DEVELOPED SEVERE AMR POST TRANSPLANTATION | Sandra Lindstedt | Received |
POS-541 | A RARE CASE EVEROLIMUS-ASSOCIATED ALVEOLAR HEMORRAGE IN A KIDNEY TRANSPLANT RECIPIENT. | Marco Busutti | Received |
POS-542 | SYSTEMIZING GUIDELINES, MEMORANDA AND ROUTINES WITH ADDITIONAL CASE MEETINGS A TRANSPLANT COORDINATORS ON CALL BOOK AND A COORDINATORS CLUB | Caroline Stolt | Received |
POS-543 | SALVAGING GRAFT PANCREAS IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANT RECIPIENT WITH SPLENIC ARTERY THROMBOSIS AND STENTING OF Y ARTERIAL GRAFT STENOSIS | Dr Devprakash Choudhary | Received |
POS-544 | EFFECTS OF COMPLETE IMMUNOSUPPRESSION SUSPENSION AFTER PANCREATIC GRAFT LOSS. | Emanuele Federico Kauffmann | Received |
POS-545 | THE FIRST EXPERIENCE OF RETROPERITONEAL TRANSPLANTATION OF THE DISTAL SEGMENT OF PANCREAS USING A PANCREATICOJEJUNAL ANASTOMOSIS ON A ROUX-EN-Y LOOP | Alexey Pinchuk | Received |
POS-546 | BEING AHEAD OF THE GAME. ORGAN OPTIMISATION PRIOR TO THE MOBILISATION OF A FULL CARDIOTHORACIC RETRIEVAL TEAM. THE NURSES EXPERIENCE. | Jen Baxter | Received |
POS-547 | NURSING MANAGEMENT IN POST-OPERATIVE PEDIATRIC LIVER TRANSPLANTATION: OUR EXPERIENCE | Elisabetta Rossetto | Received |
POS-548 | MAINTAINING AND DELIVERING A WORLD CLASS EDUCATION SERVICE TO SPECIALIST NURSES IN ORGAN DONATION DURING A PANDEMIC | Susan Lee | Received |
POS-549 | ALEMTUZUMAB INDUCTION ALLOWS THE EFFECTIVE USE OF CYCLOSPORINE A IN STEROID-FREE REGIMES OF IMMUNOSUPPRESSIVE TREATMENT AFTER KIDNEY TRANSPLANTATION | Aleh Kalachyk | Received |
POS-730 | THE STATE OF INTERSTITIAL GLUCOSE METABOLISM IN DECEASED DONOR LIVER DURING STATIC COLD STORAGE MAY PREDICT ORGAN VIABILITY AND INITIAL GRAFT FUNCTION | Alexander Sushkov | Received |
POS-732 | THE ROLE OF HLA ANTIGENTS ON COVID-19 INFECTION IN KIDNEY TRANSPLANT RECIPIENTS | Ivana Dedinska | Received |
POS-735 | USABILITY OF AN INTERACTIVE HEALTH TECHNOLOGY FOR KIDNEY LIVING DONORS ASSESSMENT: TOWARDS A STANDARDIZED INFORMED PROCESS | Fernanda Ortiz | Received |
POS-737 | INFLUENCE OF IMMUNOSUPPRESSIVE DRUG TROUGH LEVELS ON NK CELLS IN LIVER TRANSPLANTATION | Rongrong Qin | Received |
POS-741 | THE PARADOX EFFECT OF PRE-TRANSPLANT LOCO-REGIONAL THERAPIES ON CANCER RELATED DEATH AFTER LIVER TRANSPLANTION FOR HCC | Jacopo Lanari | Received |
POS-742 | THE USEFULNESS OF CONTRAST-ENHANCED ULTRASOUND IN PREDICTING THE OUTCOME OF KIDNEY TRANSPLANTS | Valentina Iori | Received |
POS-743 | A clinical lifestyle dashboard using routine clinical care data to improve kidney transplantation care | jip van den berg | Received |
POS-744 | TOWARDS ROUTINE SURVEILLANCE OF KIDNEY ALLOGRAFT REJECTION USING A FULLY AUTOMATED URINARY CXCL9 AND CXCL10 IMMUNOASSAY AND A WEB APPLICATION | Claire Tinel | Received |
POS-746 | OUTCOMES OF AKI IN RENAL TRANSPLANT RECIPIENTS WITH COVID-19 INFECTION: A TRAINEE-LED, MULTICENTRE, INTERNATIONAL REGISTRY STUDY | Matthew Bottomley | Received |
POS-747 | PREDICTORS OF OUTCOMES IN COVID-19 POSITIVE ABDOMINAL ORGAN TRANSPLANT | Aaron Ahearn | Received |
POS-748 | HEART TRANSPLANTATION FROM CONTROLLED DONATION AFTER THE CIRCULATORY DETERMINATION OF DEATH USING THORACO-ABOMINAL NORMOTHERMIC REGIONAL PERFUSION. | Jose Moya Sanchez | Received |
POS-749 | TRANSFORMING GROWTH FACTOR BETA 1 GENE POLYMORPHISM IN PEDIATRIC LIVER RECIPIENTS | Rivada Kurabekova | Received |
POS-750 | COMPARING PHYSICAL AND PSYCHOSOCIAL OUTCOMES IN UNSPECIFIED VS. SPECIFIED KIDNEY DONORS AT 3 MONTHS AFTER DONATION: RESULTS FROM THE UK BOUND STUDY | Hannah Maple | Received |
POS-752 | FACTORS INFLUENCING ACCESS TO KIDNEY TRANSPLANTATION (FIAT): FIRST RESULTS OF STAKEHOLDERS PERSPECTIVE | Ruben van Merweland | Received |
POS-753 | OPINIONS ON COVID-19 VACCINATION IN TRANSPLANTATION: RESULTS OF A NATIONAL SURVEY | Bynvant Sandhu | Received |
POS-754 | NEOPLASTIC LESIONS IN TRANSPLANTED PATIENTS: THE CANCER GENESIS | Federica Masci | Received |
POS-755 | NON-HLA ANTIBODY STUDY IN ANTIBODY-MEDIATED REJECTION IN A SPANISH MULTICENTER COHORT | David San Segundo Arribas | Received |
POS-756 | THE SMALL-MOLECULE BCL6-INHIBITOR 79-6 SUPPRESSES FOLLICULAR T HELPER CELL DIFFERENTIATION AND PLASMA BLAST FORMATION | Rens Kraaijeveld | Received |
POS-757 | A SINGLE-CENTRE ANALYSIS OF ELDERLY (=70 YEARS) DONATION AFTER CIRCULATORY DEATH (DCD) KIDNEY TRANSPLANT OUTCOMES | Susanna Lam | Received |
POS-758 | FAMILY BEREAVEMENT AND ORGAN DONATION. A PROSPECTIVE LONGITUDINAL OBSERVATIONAL STUDY IN ANDALUSIA | María Victoria Martínez López | Received |
POS-761 | EVEROLIMUS IN HEART RECIPIENTS FOR PROTECTING RENAL FAILURE: A SINGLE-CENTER RUSSIAN EXPERIENCE | Nadegda Koloskova | Received |
POS-762 | THE IMPACT OF INTRA-ABDOMINAL HYPERTENSION AFTER LIVER TRANSPLANTATION IN ADULT PATIENTS | Ivan Vella | Received |
POS-763 | STEATOTIC LIVER ALLOGRAFTS APPEAR TO INCREASE THE RISK OF POSTOPERATIVE SEVERE KIDNEY INJURY REQUIRING CONTINUOUS VENO-VENOUS HEMOFILTRATION | Remo Alessandris | Received |
POS-766 | ABSENCE OF RESUSCITATION DURING NORMOTHERMIC REGIONAL PERFUSION USING A PORTABLE GAMMA-CAMERA SYSTEM | José Moya Sánchez | Received |
POS-767 | GENETIC VARIABILITY IN GLUCOCORTICOID PATHWAY AND NEW ONSET DIABETES MELLITUS AFTER TRANSPLANTATION | Gregor Mlinsek | Received |
POS-768 | DECIPHERING BIOLOGICAL DETERMINANTS OF PREFORMED T AND B-CELL ALLOSENSITIZATION IN KIDNEY TRANSPLANT CANDIDATES | VINCENT PERNIN | Received |
POS-771 | PROSPECTIVE ASSESSMENT OF GRAFT RECOVERY AFTER KIDNEY TRANSPLANTATION BY MEANS OF DONOR-DERIVED CELL-FREE DNA | David Cucchiari | Received |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|